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Abstract
Hybridoma cells were grown in dialysis perfusion culture using a stirred reactor 
within which a tubular membrane was suspended. Nutrient and product flows 
occurred by diffusion processes alone, and were both to and from the culture envi- 
ronment A mathematical model of the transfer and reaction allowed prediction of 
steady state cell and metabolite concentrations. Steady states in cell concentra- 
tion were observed for a range of perfusion rates and membrane areas. However 
the model could not be applied to predict steady state cell concentrations between 
changes in the medium. The perfusate consisted of basal medium only. Serum ad- 
dition to the reactor itself resulted in decreased steady state cell densities except 
when it relieved a glucose limitation.
Antibody was accumulated to high concentrations and yields on both basal 
medium and serum were many times those achieved in standard batch cultures. 
Cell viability fell to 30-50% but product quality did not appear to be adversely 
affected by the low viability.
Recombinant CHO-320 cells also grew successfully under dialysis conditions 
and produced 7-interferon. Cell concentrations and viabilities were higher than 
those seen with the hybridoma. The insect cell line SF9 did not grow during 
dialysis perfusion, but post infection with a recombinant Baculovirus permitted 
the yield of ^-galactosidase to double in dialysis culture.
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Chapter 1
Introduction
1.1 Why grow animal cells?
Two discoveries during the 1970s prompted a renewed interest in growing ani- 
mal cells which had for some time been used to produce viruses. The develop- 
ment of the hybridoma by Kohler and Milstein (1975) permitted the production 
of monoclonal antibodies, revolutionising the identification of complex biological 
molecules. The other discovery by Cohen et al. (1973) was a method of recombin- 
ing DNA in vitro. This allowed for the first time the production of human proteins 
which previously were only available by purification from human tissue, often in 
vanishingly small concentrations. Genes could be expressed in organisms other 
than those in which the gene had evolved. Both discoveries were to have profound 
effects on the development of novel therapeutic drugs. To date there are about 
20 proteins registered as drugs produced using these techniques (Drews, 1993), 
with about 150 recombinant proteins and more than 40 monoclonal antibodies at 
some stage of clinical development. In this project principally hybridoma but also 
recombinant systems were used.
1
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1.1.1 Hybridomas
Hybridoma cells are developed from white blood cells. White blood cells are a 
crucial part of the immune system of all vertebrates and can be divided into 
two classes, myeloid cells and lymphoid cells. An average human adult has ap- 
proximately 10 12 lymphocytes, around 2% of total body weight and produces 109 
lymphocytes per day (Roitt et a/., 1990). B-lymphocytes make up 5-15% of the 
circulating lymphoid pool and these cells produce a type of protein known as im- 
munoglobulin, or antibody, which binds specifically to foreign matter within the 
body. Each B-cell produces only one specific antibody which, through a combina- 
tion of chemical and steric factors, binds to a particular chemical structure, the 
antigen. A series of random genetic rearrangements give in excess of 108 possible 
different antibodies (Burnet, 1959). Those clones that produce antibody which 
correspond to antigens that are normally part of the body are held quiescent, or 
are deleted. This is known as the clonal selection hypothesis, first proposed by 
Burnet (1959).
Immunoglobulin is a major constituent of the protein of human serum. There 
are five classes of antibody: IgA, IgD, IgE, IgG and IgM. IgG accounts for 70-75% 
of the total immunoglobulin pool, and is a monomeric protein with a molecular 
weight of 146,000 consisting of 4 polypeptide chains; 2 light chains with a molec- 
ular weight of 25,000 and 2 heavy chains with a molecular weight of 51,000 (see 
Figure 2), held together by disulphide bonds. All immunoglobulins are glycopro- 
teins, the carbohydrate content of IgG forming 2-3% of their mass. There are four 
subclasses of IgG, each having a different heavy chain. The heavy chains differ in 
amino acid sequence and inter-chain disulphide bond linkages.
Both the light and heavy chains have two sections made up of constant and
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Figure 2: A schematic diagram of IgG
variable regions. The variable region of each light and heavy chain is unique to that 
particular B-cell clone. In the complete antibody molecule, this variable region 
forms an antigen binding site. IgG is a Y shaped molecule and possesses two such 
binding sites. Binding to the antigen is determined by steric factors (it. how well 
it fits into the binding site) and chemical factors (it. the presence of appropriate 
moieties to bind with). The specificity of the antibody/antigen complex can be 
very high. Antibodies are capable of distinguishing between small differences in 
the primary structure of the antigen, differences in charge and differences in steric 
conformation. For example, antibodies can be raised against a-helical tripeptide, 
which do not bind the same tripeptide in non-helical form. The constant region 
forms the remaining three domains of the four domain IgG and this part of the 
molecule includes sites specific for a variety of cells of the immune system and 
the activation of blood clotting, complement. The many binding functions of IgG 
have earned it the epithet The Flexible Adapter and its primary role in the 
immune system is to facilitate the recognition of foreign bodies by the cells of the 
immune system.
Hybridomas are produced by fusing Plasmocytoma cells with B-lymphocytes. 
Plasmocytomas are a type of B-lymphocyte cancer. It is possible to grow them
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indefinitely in vitro while normal lymphocytes only survive for 1-2 weeks. A num- 
ber of mouse derived plasmocy toma lines exist which do not produce antibody and 
also have lost the enzyme Hypoxanthine guanosine ribosyl transferase and 
consequently cannot synthesise deoxyribose nucleic acids via the salvage pathway 
and must rely on the de-novo pathway. Aminopterin inhibits Dihydrofolate Re- 
ductase thus blocking the regeneration of tetrahydrofolate, which is necessary 
for de-novo DNA synthesis. In the presence of aminopterin, these plasmocytoma 
cells die. It is possible to take the lymphocytes from a mouses spleen and fuse 
them with plasmocytoma cells. The majority of such fusions are genetically un- 
stable and die. The cells are then grown in medium containing Aminopterin, 
along with Hypoxanthine and Thymidine to allow cell growth using the salvage 
pathway. Unfused myelomas die because of the aminopterin, unfused spleen cells 
die because they are not transformed. The resulting remaining cells are called 
Hybridomas. Diluting the cells, so that on average there will only be one cell 
per sample, allows separation of the different clones. Clones producing antibodies 
of interest are detected using ELISA (see below).
1.1.1.1 Why Grow Hybridomas?
Many biological molecules are difficult to identify with conventional chemical tests 
because of their complexity. The specificity of antibodies allows molecules of in- 
terest to be specifically labelled. The antibody can be tagged with a radioisotope, 
an enzyme, or a fluorescent chemical to allow identification (see Figure 3). If the 
antigen is attached to a solid support, then unbound antibody may be washed 
away and qualitative or quantitative assessment of either the antigen or antibody 
can be made. This technique is known as the Enzyme Linked Immunosorbant
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Assay (ELISA). It is now used routinely in medical laboratories throughout the 
world for many diagnostic tests, two such uses being the determination of viral 
antigens eg. HIV and measurement of hormone concentrations eg. in pregnancy 
testing.
The antibodies for such tests can either be from a hybridoma and thus mono- 
clonal, or from the serum of animals which have been immunised with the antigen 
of interest. Since one antigen may contain several potential sites for antigen bind- 
ing, epitopes, and each epitope may be bound by several different antibodies then 
such serum is said to be polyclonal. Polyclonal sera, in most cases, are suffi- 
ciently specific for assay purposes, however, they are not sufficiently specific for 
other uses. Hybridomas may be grown in mice within a form of hollow tumor, 
known as an ascitic tumor and antibody may be recovered in 1-10 mg/ml con- 
centrations in 1-10 ml volume. For production of small amounts of monoclonal 
antibody for diagnostic purposes, this has been the method of choice in many 
laboratories. However there are ethical concerns about its use, logistical prob- 
lems if large quantities are required and, because of the animal host, difficulties 
in getting licenses for therapeutic purposes. Early in-vitro production methods 
used batch cultures, either in large agitated tanks, or in roller bottles, producing 
10-100 y^g/ml of monoclonal antibody, depending on the cell line, at scales of up 
to 10,000 litres. In-vitro production is more reproducible and consistent than as- 
citic culture and it is possible to produce the humanised antibodies that would be 
needed for therapeutic applications.
CHAPTER 1. INTRODUCTION 6
Colour -*-N
J^
Identification Tag Enzyme Fluorescence Radioisotope
Figure 3: Conjugated tags used to identify the presence of antibody
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1.1.1.2 Uses For Antibodies
Antibodies have many uses including:
  Diagnostics
Many biological molecules are difficult to identify and quantify using con- 
ventional biochemical techniques, and antibodies are now routinely used for 
bacterial and viral identification, and quantification of proteins, hormones, 
etc.
• Tumor Imaging
By attaching a radioactive label to an antibody directed against a cancer 
cell, tumors can be located then surgically removed.
  Drug Targeting
Pharmaceuticals may be concentrated around a cell type of interest, eg. 
cancer cells, by attaching them to an antibody. This is known as Ehrlichs 
Magic Bullet.
  Direct Immunisation
Antibodies raised against a disease-causing agent can be used to give short 
term protection.
  Purification
A type of affinity chromatography, the antibodies recover the item of interest 
which is released by changing the pH or ionic strength of the buffer.
  Catalysis
If the transitional state of a chemical reaction can be stablised, antibod- 
ies may be raised to it. In some cases, these antibodies then catalyse the 
reaction.
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Table 1: Therapeutic products of recombinant DNA technology and animal cell 
culture
Growth Factors Cancer, anemia, wound healing, viral and
	bacterial infections, bone marrow transplantation 
Hormones Diabetes, growth disorders, osteoporosis 
Interferons Cancer, viral infections 
Interleukins Cancer 
Fibrinolytics Cardiovascular diseases
Vaccines Hepatitis-B, AIDS, malaria, pertussis, typhus, influenza
Recombinant Antibodies Cancer, infections, inflammation
Soluble Receptors Inflammation, HIV infection
Enzymes Enzyme deficiencies
1.1.2 Recombinant DNA technology
The second development mentioned earlier, recombinant DNA technology has 
permitted tremendous developments in the understanding of biological systems 
over the last 20 years. The ability to transfer genes from one organism to another 
and to modulate the level to which they are expressed, has offered the possibility 
of new and improved therapies for a range of diseases. These are just starting 
to reach the market and products of recombinant DNA technology are currently 
undergoing clinical trial (Table 1). (Drews, 1993).
The tools for performing DNA recombination come from bacteria, from which 
can be isolated both a variety of enzymes that split DNA at very specific sequences 
and others that rejoin the DNA. Careful use of these tools allows the production 
of a new length of DNA encoding a novel combination of functions enabling the 
production of the protein of interest. For successful protein production a num- 
ber of different functions must be performed, many of which are controlled by
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the DNA sequence. Firstly, the DNA must be able to enter the host organism, 
secondly, in many cases, it needs to be transferred with the host DNA when the 
cell divides, thirdly, it must be translated and transcribed in the host organism; 
and fourthly it may need to be modified and secreted. A Vector is a length of 
DNA which combines those functions which are controlled by DNA for expression 
of the protein. Vectors are often based on naturally occurring viruses. Other 
functions are controlled by the host organism, or expression system, which in 
turn influences the vector chosen.
The first function, insertion of the DNA, can be achieved in a number of ways. 
The DNA molecule may be injected in to the cell, the cell may made permeable 
using a variety of chemical or electrical treatments, or, if the vector is a suitable 
virus, the molecule may be packaged in the coat proteins of the vector and the 
normal viral uptake mechanism may be used.
The second function, transfer of DNA to progeny, can be ignored if the vec- 
tor is a virus that efficiently infects, then lyses its host, such as the baculovirus 
system. This gives transient protein production. Normally continuous production 
is desired, to ensure transmission of the recombinant molecule to the progeny. 
This may be achieved by a number of different strategies, for example the vector 
may recombine itself with the host genome or be present in high copy number, 
it may encode resistance to a cytotoxic drug, or conferring an essential metabolic 
function.
The third function is protein production. The controlling stage here is ini- 
tiation of transcription, which is regulated by a DNA sequence known as the 
promoter. Promoters vary in the strength of their action, by about 100 fold and 
may be either constitutive, always on, or inducible, may be switched on and off.
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Most vectors contain strong constitutive promoters, often from viruses such as 
simian virus 40 (SV40).
The fourth function, correct modification and secretion of the resulting protein 
is strongly affected by the type of host organism. Recombinant proteins may 
be expressed in many different organisms, as John Hodgson says in Expression 
Systems: a user's guide (Hodgson, 1993):
... producer organisms... span six orders of magnitude from E. coli 
weighing in at around one micrometer in length to the heavyweight 
lactaters and bleeders, Bos taurus, Ovis aries and Sus domesticus at 
over one meter.
The choice of which organism to express your protein in is a complex one. Many 
human proteins are substantially altered subsequent to translation; peptides may 
be cleaved from them, certain amino acids are chemically altered, and carbohy- 
drate groups may be added. In addition human cells have a number of proteins 
known as chaperonins which assist the nascent peptide chains to fold into the cor- 
rect tertiary structures. These modifications may be necessary for the functioning 
of the protein. Also, incorrectly modified protein may provoke an immune response 
if used in vivo. Bacteria lack the ability to perform many post-translational mod- 
ifications, and many proteins expressed intracellularly form insoluble denatured 
pellets known as inclusion bodies which must be refolded to become active. How- 
ever bacteria are substantially cheaper to grow and yield higher concentrations 
of protein in shorter periods of time. A recent study (Datar et a/., 1993) com- 
pared the production of tissue Plasminogen Activator (tPA), which is given to 
myocardial infarction patients to stimulate blood clot dissolution, in Escherichia 
coli and Chinese Hamster Ovary (CHO) cells. E.coli produced 460 mg I" 1 in
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1-2 days, CHO produced 33.5 mg I" 1 in 5-7 days. Bacterially produced tPA was 
present as a denatured mass and the costs involved in refolding the tPA made it 
more expensive per gram than the CHO tPA.
1.2 What Controls Reactor Productivity?
Both hybridoma and recombinant DNA technology involve using animal cells to 
make the product protein. However animal cells are expensive to grow because 
of the high medium cost, low cell densities and low specific productivities. It 
is therefore important to understand what factors affect the productivity of any 
production system. This may be considered at two, interlinked, levels; firstly 
factors that operate at the level of the reactor; secondly factors that operate at 
the level of the cell.
1.2.1 Reactor Design
The amount of antibody produced by a reactor is a complex function of a number 
of different parameters (see Figure 4). The two principle effects of reactor opera- 
tion are cell density and specific productivity which is dealt with in the next 
section.
Cell concentration is a variable with a considerable scope for adjustment in 
animal cell culture. Batch in-vitro cultures of hybridoma cells generally reach a 
maximum cell number at around 1-4xlO6 cells ml" 1 and there is often little or 
no stationary phase. Mammalian tissue has a cell concentration of around 1 x 109 
cells ml" 1 , five hundred times higher than that of the batch culture and this cell 
density is maintained, not transient as in the case of a culture. So, a 1 litre
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Figure 4: Factors affecting reactor productivity
bioreactor of the size and cell density of a human liver, could replace Celltech's 
2000 litre airlift bioreactor (Birch et a/., 1985) if in-vivo cell densities could be 
reproduced.
Nutrient supply modes affect both cell density and specific productivity. 
Supply may be either batch or continuous. Batch operation modes are inherently 
limited by nutrient supply or toxin removal and therefore cell densities are low. 
Continuous operation modes produce a homeostatic control of chemical conditions 
within the reactor, giving intensified cell concentrations and extending operation. 
Cells at high cell densities require less (expensive) serum (Petricciani, 1987; Lee 
et a/., 1991; Ray et a/., 1989) and they use less nutrients (Wohlpart et a/., 1990). 
This may be due to production of high molecular weight effectors produced, called 
autocrine factors (Lee et a/., 1991). Some such intensive systems, for example 
hollow fibre systems, can reach cell densities in the x 108 ml" 1 range and maintain 
them for periods of months (Wang et a/., 1989). For most systems, the resulting
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antibody concentration is much higher than that observed in batch culture, as is 
its ratio to the total culture protein concentration and this eases the purification of 
the antibody. However the practical problems of avoiding concentration gradients 
particularly of oxygen in such devices limits the overall volume.
Continuous nutrient supply accrues advantages in reactor operation; for exam- 
ple the frequency with which the reactor needs to be turned round is decreased. 
Also the use of a smaller inoculum permits a reduction in the number of stages 
required in inoculum preparation. However the systems are more complex than 
batch systems and with complexity comes increased probability of error. Also, 
more complicated systems are more costly to validate.
A larger volume obviously gives more cells and thus more product. But, be- 
cause oxygen is poorly soluble in water, it is difficult to supply it sufficiently fast 
at the highest cell densities (xlO8 cells ml" 1 ) unless the diffusion path the oxygen 
has to take is minimised by putting its supply very close to the cells, for example 
in hollow fibre devices.
Medium composition also affects the cell density achieved. Each cell line's 
requirements are, however, individual. Optimal medium composition also depends 
on how the reactor is operated. Batch operation may require higher concentrations 
of some nutrients than do continuous operation modes, to achieve the maximum 
possible cell density.
1.2.2 Specific Productivity
• mRNA concentration The level of mRNA transcripts of a particular 
gene is the result of a balance between transcription and transcript degra- 
dation. Since protein synthesis is normally limited by the rate of mRNA
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Figure 5: Factors affecting specific productivity
to Ribosome binding, altering the mRNA concentration, for example by 
increasing the gene copy number, will increase the amount of transcribed 
protein. There is little evidence however that changes in reactor conditions 
alter gene expression levels per se. For example, changes in growth rate pro- 
duce little variation in light and heavy chain mRNA levels in hybridomas 
(Merton et a/., 1991; Bibila and Flickinger, 1991).
• Cell Cycle Several authors have shown that specific productivity in- 
creases under conditions of stress, for example; during the death phase of 
batch cultures, at low growth rates in chemostats and under conditions of 
mechanical stress (Ray et a/., 1989; Feder, 1987; Lee et a/., 1992). It has 
been shown that at low growth rates, hybridoma cells spend longer periods 
of time in the Gl portion of the cell cycle and in this phase they synthesise
/
more antibody (Al-Rubeai et a/., 1990; Ramirez and Mutharasan, 1990).
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• Cell Turnover Hybridoma cells store a portion of the antibody they 
produce and this is released when the cells die (Al-Rubeai and Emery, 1990) 
so conditions of stress, where death rates increase passive release of antibody, 
contribute to improved specific productivity.
• Reactor Operation Mode Steady state conditions, arising in some 
continuous operation modes, allow the cells to expend less energy on contin- 
uous physiological adaption to a continuously changing environment (Miller 
et a/., 1989a).
• Medium Composition Both product production and quality can be 
affected by the composition of the medium in which they are grown. Dalila 
and Ollis (1989) showed for a hybridoma cell line that specific productiv- 
ity increased linearly with serum concentration. Al Rubeai et al. (1992) 
showed that addition of Pluronic F68 increased the specific productivity of 
a hybridoma cell line in continuous culture by increasing the proportion of 
time that the cell spends in Gl. They also showed that addition of un- 
phy siologically high concentrations of thy mi dine, arrests cells in Gl and so 
increases productivity. As for product quality, Hayter et al. (1992a) showed 
for recombinant CHO producing human interferon-7, that the proportion of 
the product that was glycosylated decreased when the cell was grown in a 
glucose limited chemostat.
1.2.3 Problems in Comparing Systems
Comparison between different reports in the literature of systems used for cell cul- 
ture is difficult because groups have used different cell lines, and have not reported
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their results in a consistent manner. Hybridoma cell lines can be physiologically 
very different from each other.
  Cell specific antibody productivity can vary from zero to 70xlO~9 g cell" 1 
day' 1 .
  Many hybridoma cell lines contain a non-producing subpopulation, which 
can vary in proportion according to the growth conditions (Chuck and Pals- 
son, 1992).
  Metabolism can vary considerably between clones, affecting the efficiency of 
the use of the medium. For example, ammonium toxicity varies between cell 
lines (Ozturk et a/., 1992; McQueen and Bailey, 1991; Hassell et a/., 1991).
For reactor systems where cells are attached to a surface, reactor volume is not 
a good indicator of the total cell capacity of the system. Surface area, or an 
indication of surface area, is more apposite. Some system configurations retain 
antibody which is harvested periodically and is therefore present at concentra- 
tions of mg ml" 1 . Others do not and antibody is then present at 100's of fj,g ml"1 . 
Different system configurations are thus difficult to compare. Many different in- 
dicators of reactor "efficiency" are used. For example, total mass of antibody 
produced, reactor productivity in grams per hour, or grams per litre per hour, 
yield on medium, cell specific productivity and process improvement factors over 
batch culture. Many authors do not report their reactor productivity adequately 
to allow comparison between systems, though a few comparative studies have been 
attempted (Heath and Belfort, 1987; Schlaegar and Schumpp, 1992). The results 
of a batch culture form a good basis for comparison as this is widely regarded as 
being the base case. All reports on reactor systems should detail the performance
CHAFTER 1. INTRODUCTION 17
of their cell lines in batch culture, using the same, or as similar as possible, media 
to aid comparison, quoting maximum cell density, viability index (total number 
of viable cell hours), maximum antibody concentration and cell specific antibody 
production rates; quoting as many as possible of these for the intensified reactor 
system also.
1.3 How to intensify
Cell cultures are generally limited either because one or more nutrients are entirely 
consumed, or because of the accumulation of toxic metabolites. Intensified pro- 
duction is achieved by exchanging culture fluid for fresh medium, whilst retaining 
the cells within the reactor. This is known as perfusion. In hybridoma culture, the 
main energy sources are glucose and glutamine, whilst their metabolism produces 
toxic compounds, including ammonia from glutamine and lactate from glucose 
and glutamine. Hybridoma batch cultures are reported to be limited by one of 
these four compounds (Reuveny et a/., 1987). The concentrations of glucose and 
glutamine in the medium are constrained by the tolerance of the cells for their 
by-products. Local concentration gradients within a system could lead to cell 
death while the overall concentrations were not limiting. Therefore most systems 
are designed to minimise these gradients by one of two methods; either the cells 
are kept in a stirred homogeneous environment, in which case cell densities in 
the range of 1 x 106-5 x 107 are achieved and large volumes may be used (< 
1000 litre); alternatively, the cells are confined to a support and the maximum 
distance between the medium supply and the cells is kept short. These are the so 
called heterogeneous cultures, in which cell densities of 1 x 107-5 x 108 can occur,
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volumes are however much smaller (< litre) and it is often difficult to access the 
biomass.
1.3.1 Heterogeneous Culture Systems
By attaching cells to a solid surface, or confining them behind a membrane, cells 
may be retained within the reactor. Such intensified systems tend to reach very 
high cell concentrations, up to 5 x 108 cells ml" 1 . As some or all of the the cells are 
attached to a surface, they are locally at tissue-like cell densities. Extracellular 
matrix and desmosomes (cell junctions) may be produced, which can affect cell 
growth and protein production (Vournakis and Rundstadler, 1989). The previ- 
ously mentioned autocrine effects will be at their most effective. Also mechanical 
stresses caused by bulk fluid flow, or gassed aeration, which can cause cell damage, 
are avoided.
Most heterogeneous systems do not, however, successfully avoid heterogeneity 
in their cell populations caused by local concentration gradients (Hu and Peshwa, 
1991). The range of conditions means that exact control over cell physiology is, 
therefore, not possible.
1.3.1.1 Entrapment
Cells may be entrapped within polymeric meshes. For example, alginate, car- 
rageenan, agarose and poly aery lamide have all been used to produce beads en- 
trapping cells at densities of approximately xlO7 cells ml" 1 . The entrapping 
polymer must exhibit a matrix with pore sizes as large as possible, to allow nu- 
trient transport through the gel whilst being fine enough to entrap the cells and 
the method of entrapment must be gentle, so as to not damage the cells. For
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example, polymeristion of alginate is achieved by dropping the cell-alginate sus- 
pension into a CaCl2 solution. This can be done at physiological temperature 
and osmolarity. However bead size should be kept small. Al-Rubeai et al. (1989) 
found for alginate entrapped hybridoma, that cells were metabolically active only 
in the outer 0.24 mm. Thus bead diameter should be kept to less than 0.5 mm, 
as diffusion limitations can result in heterogeneous cell populations. Cell numbers 
of 5xl07 cells ml" 1 have been recorded within the beads themselves (Smidsrod 
and Skjok Broak, 1990), though the beads occupy 20-50% of the available space 
in the reactor, so the effective cell density is lower.
1.3.1.2 Membrane Systems
Cells my be entrapped behind membranes of a number of different configurations, 
the most popular being the hollow fibre. Hollow fibre cartridges have been likened 
to artificial capillaries. Cells are normally grown in the extracapillary space, where 
they may be in suspension, or attached to the wall of the hollow fibre, which in 
some types of fibre has a support material on the outer surface to which cells 
may attach. Medium is passed through the lumen of the fibre wherein diffusive 
exchange may occur.
Mixing inside the extracapillary space is caused by the flow of liquid in the 
lumen, the Starling effect. However nutrient and oxygen gradients occur both 
axially and radially. The hollow fibre may be operated in a convective filtration 
mode, with medium being forced through the hollow fibre from the cartridge 
side and out through the lumen. Nutrient gradients are reduced, but membrane 
clogging may occur. Hollow fibres are available in a range of molecular weight 
cut-offs and generally, for hybridoma culture, a value is chosen that will retain
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the antibody within the extracapillary space, the antibody may be harvested 
periodically. Cell concentrations reach 5xl08 cells ml"1 and systems have been 
run for months (Kidwell, 1989; van Erp et a/., 1991b; Wang et a/., 1989). In 
retained antibody systems, antibody concentrations can reach mg ml" 1 levels. In 
practice, hollow fibre cartridges are limited in transfer area to a maximum of 2-4 
m2 each and further expansion must be by using multiple cartridges.
There are also several types of flat sheet membrane reactors (Kargi et al, 1989). 
These systems allow improved access to the biomass and the distance between the 
cells and the medium supply can be closely controlled. However these have lower 
surface area to volume ratios than hollow fibre systems and are more difficult to 
construct as well as to operate.
Another form of membrane reactor is the microcapsule, first commercialised 
by Damon Biotechnology Inc (Duff, 1985). Cells are entrapped in alginate beads, 
which are then coated in polylysine (Duff, 1985) or other materials (Grootwassink 
et a/., 1992; Tsai and Chu, 1989; Gharapetian et a/., 1986), and the alginate gel 
may then be reliquified. The polylysine membrane pore size can be controlled and, 
for monoclonal antibody production, is adjusted so that antibody is retained. Cell 
concentrations in the range of xlO8 ml" 1 are observed within the microcapsules 
and antibody is recovered at mg ml"1 concentrations when the microcapsules are 
filtered off and opened up.
1.3.1.3 Adsorption
Micro carriers were developed by (van Wezel, 1967) for growth of attached cell 
lines. Many different materials have been used, including glass, polystyrene, cel- 
lulose, gelatin and dextran. However hybridomas attach only poorly to surfaces.
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Glass microcarriers have been used in packed beds (Ramirez and Mutharasan, 
1989), where the cell retainment is partly by entrapment. More successful has 
been the use of porous support materials, for example macroporous microcarriers. 
The use of macroporous microcarriers increases the area available for attached 
cell growth through the use of large pores which may make up 90% of the volume 
of the carrier. Cells within the pores are also protected from mechanical stresses. 
Verax Corporation has heavily promoted the use of collagen macroporous micro- 
carriers (Vournakis and Rundstadler, 1989), which are used in a fluidised bed and 
it is claimed that pressure differences across the height of the bed cause flow of 
culture fluid through the bead and, when this is combined with tumbling of the 
bead good fluid exchange occurs within the bead. Racher et al. (1990) have grown 
hybridoma on glass macroporous microcarriers in a packed bed, giving 3x 107 cells 
ml" 1 . They concluded that monoclonal antibody production was limited by the 
rate of oxygen diffusion into the microcarrier. Many other porous support mate- 
rials have been tried in fluidised or packed beds, including for example polyester, 
polyurethane or polystyrene (Jan et a/., 1992; Yamaji and Fukuda, 1992) or retic- 
ulated carbon (Kent and Mutharasan, 1992).
1.3.2 Homogeneous Culture 
1.3.2.1 Filtration
Hollow fibres and wire mesh have been used successfully for separating cells from 
the medium. Tangential flow filtration involves placing a recirculation loop ex- 
ternally to a reactor which includes a hollow fibre cartridge, generally with a 0.2 
//ra pore size (Feder, 1987; Velez et a/., 1990; Pinton et a/., 1991). Concentrations 
of cells an order of magnitude higher than in batch culture are obtainable and
CHAFTER 1. INTRODUCTION 22
hundreds of //g ml~ 1 of antibody can be produced in the product stream. The 
cells, however, must be pumped around the loop causing both mechanical stress 
and changes in the chemical environment around the cell. Membrane fouling may 
occur but, with an external filtration unit, replacement is possible.
The spin filter consists of a rotating wire cage, often mounted on the agitation 
shaft. Mesh sizes from 25-60//m can be used and, although this is larger than the 
diameter of the cell (10-18 /mi) cell retention of 95% can be achieved (Jan, 1992). 
Process improvements similar to those in tangential flow filtration systems can be 
achieved and filter fouling may be avoided by the use of higher rotational speeds 
and by selection of appropriate materials for filter construction. It is however, 
more difficult to deal with when it does occur.
1.3.2.2 Sedimentation
Cells may be removed from the product stream by gravitational settling. The 
out-flow goes through a region where the flow is slowed by expanding the area 
available for flow. Cells settle in this region and return to the fermenter (Tokashiki 
and Arai, 1989). Cells may also be separated by centrifugation (Tokashiki et a/., 
1990; Vanwie et a/., 1991), but these methods produce only moderate increases 
in cell concentrations, are tricky to set up and, particularly in the case of the 
centrifuges, are mechanically complex.
1.3.3 Dialysis Culture
Dialysis culture is a form of culture whereby molecules up to a certain size are 
allowed to diffuse freely across a membrane in both directions. Larger molecules 
will not pass through the pores. Dialysis will not involve any net transport of
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mass unless there is a difference in mechanical or osmotic pressure across the 
membrane. The retention of high molecular weight components means that only 
low molecular weight medium need be fed in the permeating stream, which would 
give a considerable cost saving. It also means that high molecular weight products 
are retained within the reactor and may accumulate to high concentrations.
Dialysis culture was first used in 1896 by Metchnikoff, Roux and Salembini 
1896, who used colloidal sacs filled with cultures of Vibrio cholera placed in the 
peritoneum of animals to prove the existence of a soluble toxin and the effect of 
anti-toxin. The first in vitro use was by Carnot and Fournier (1900) who used it 
to obtain toxin from Pneumococci. Since then dialysis has been used extensively 
in vivo, for the study of soluble toxins in disease, or the role of serum factors in 
cell growth. In vitro, it has been used to enhance production of toxins, enzymes, 
polysaccharides, etc.] or to study interactions between organisms.
The first in vitro growth of animal cells in a dialysis mode was in 1960 by 
Eagle (1960) who placed cells in basal medium inside a dialysis membrane, with 
serum containing medium outside, to investigate the requirement of cells for the 
protein component of serum. Adamson et al (1983) in 1983 were the first to grow 
hybridomas in dialysis culture. They placed 1ml aliquots of cells inside dialysis 
tubing bags, which were freely suspended in roller bottles containing medium plus 
10% serum. They achieved cell concentrations in the range of IxlO7 cells ml" 1 , 
i.e.ten-fold higher than that observed in batch culture. Antibody titres were also 
ten fold-higher. Since then many groups have reported similar results (Pannel 
and Milstein, 1992; Falkenberg et al, 1993; Sjorgren-Jansson and Jeansson, 1985; 
Mathiot et a/., 1993) using the same or similar techniques. Pannel and Milstein 
(1992) have grown a panel of 7 different hybridomas in a system whereby 30ml
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of cell suspension is placed in dialysis tubing attached diagonally across a roller 
bottle. An air space is left at the top so that, as the bottle rolls, the air bubble 
travels the length of the tubing, keeping the cells suspended. Three such tubes are 
placed in a 2 litre volume roller-bottle, filled with 1.5 litres of medium, without 
serum. The medium is replaced every other day. Their hybridomas produced 
between 1.1-2.3 mg ml"1 monoclonal antibody in 20 days. Comparing this with 
ascitic culture they found that ascitic culture, produced 7.3-10.5 fold higher IgG 
protein but, when they examined antibody activity the difference was only 1.5- 
4.7. In other words, the antibody was of a higher specific activity in the dialysis 
culture, less degraded and containing less contaminating antibody. They say:-
"More antibody is produced within one bubble chamber than in one 
mouse, with little effort and without the need for animals"
Kasehagen et al. (1991) used more sophisticated control, by placing the dialysis 
tubing, with 1 ml aliquots of cells, within a pH and dissolved oxygen tension con- 
trolled bioreactor. Inoculating at cell concentrations of above 5xl06 cells ml" 1 
no net cell growth was observed. Cell concentrations as high as IxlO8 cells ml" 1 
could, however, be maintained over a period of 5 days. This mode of dialy- 
sis culture then is successful for producing small quantities of antibody at high 
concentrations and would be a satisfactory replacement for ascitic culture for a 
laboratory wishing to produce monoclonal antibodies for its own use. The volume 
of culture can be increased by ensuring that the cell compartment is mixed and 
by choosing appropriate medium and feeding strategies. However the final volume 
is limited unless good mixing is provided in the cell compartment. Moreover no 
online control of reaction conditions including for example pH and DOT in the 
reaction space is possibly with the methods described up to now.
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The first serious attempt to solve this problem was by Gallup and Gerhardt 
1963. They identified two basic issues, membrane placement and medium replace- 
ment mode. The obvious means are to turn the system inside out, i.e. to suspend 
a tubular membrane inside a homogeneous culture volume and pass medium thr- 
ough the inside of the tube. Alternatively the culture volume may be recirculated 
through an external exchange device. They decided on the latter because it al- 
lowed independent control of fermentation, agitation and dialysis functions. They 
grew the bacterium Serratia marcescens in it, achieving viable cells densities in 
excess of xlO12 cells ml" 1 . Schultz and Gerhardt 1969, the best review by far of 
dialysis culture, describe four modes of medium supply (Figure 6). Mathematical 
models are derived for modes 1,2 and 4 describing cell concentration and nutrient 
concentration.
A comparison is shown in Table 2 of a number of systems reported, using 
the above medium. All of the reports have been published since this project was 
begun except the first two. All four modes have been used for growing animal 
cells. Different cell growth patterns were seen with the different modes. Modes 
with continuous dialysate replacement reached steady state cell concentrations. 
In all cases the authors felt it necessary to site the membrane inside the reactor 
to avoid cell damage in a circulation loop.
Most have used membranes with a molecular weight cut-off at around 10,000 
Daltons, probably principally because these are the cheapest and most readily 
available, being the standard used for dialysing solutes away from protein purifi- 
cations and in haemodialysis. The membrane area to reactor volume ratios are 
in the range 0.1-1 cm2/cm3 . Schultz and Gerhardt 1969 suggested that ratios of 
around 1 cm2 cm"3 were a reasonable target for the bacterial cultures with which
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Figure 6: Modes of operation of dialysis culture devices.
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Reference
Gori (1965)
Rookes et al. (1989)
Hagerdorn and Kargi (1990)
Comer et al (1990)
Comer et al (1990)
Bohmann et al (1992)
Mode(s)
B/C (B/B)
RB/B
B/B
RB/B
C/C
C/RB
Memb. 
Type
D
HF
D
HF
D
D
Memb. 
Cut-off
10,000
7,000
12,000
10-100,000
1,000
10,000
Reactor 
Volume
21
11
0.281
1-1000
1.31
(0.9)
Memb. Area 
to Volume
0.21
(1.0)
0.26
0.1-0.31
0.9
Table 2: A comparison of some dialysis culture systems used for the growth of 
animal cells. Mode types reservoir first, then culture:B = batch, RB = repeated 
batch, C = continuous. D = dialysis tubing, HF = hollow fibre. Figures in 
brackets are estimates
they were concerned.
Gori 1965 was the first to grow a number of different cell types in a system 
consisting of a dialysis tube medium supply inside a 1.8 litre reactor. In batch 
reactor /batch reservoir mode (see Figure 6), they observed increases in maximum 
cell concentration which depended on the the ratio of the volume of the reservoir 
to the volume of the culture. They developed equations to predict the time till 
exhaustion of the medium in the reservoir and used this in a continuous reactor 
batch reservoir system, to predict when to change the reservoir.
Batch reactor/repeated batch reservoir systems were used by Boehringer Mann- 
heim GMBH (Comer et a/., 1990), at up to the 1000 litre scale. Using hollow 
fibres of 10,000-100,000 dalton molecular weight cut off, an area for exchange 
was achieved of between 0.01 m2 l~ 1-0.3m2 I"1 . Reservoir sizes depended on the 
cultivation time, the medium and the product, with medium in the cell compart- 
ment either containing serum, or serum-free supplements. They used human and 
murine hybridoma and recombinant Chinese Hamster Ovary cells. They do not 
give full details for particular cell lines, or system configurations. Cell densities 
in excess of IxlO7 cells ml" 1 were achieved with viabilities greater than 90% and
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increases in antibody concentrations over batch culture of between 2-15 fold for 
mouse-mouse hybridomas and 15-30 fold for human-human hybridomas.
Bohmann et al. (1992) have combined the dialysis bioreactor design of Markl 
et al. (1993) with a fixed bed of glass macroporous microcarriers and a special 
agitation system to induce radial flow through the bed.
Previous work in this laboratory used hollow fibre bundles with a 7 kilodal- 
ton cut-off, suspended within the reactor and a batch reactor/batch reservoir sys- 
tems, with daily replacement of the perfusate volume and periodic serum addition 
(Rookes et a/., 1989). Cell numbers peaked at 8xl06 cells ml" 1 , antibody reached 
600 //g ml" 1 , 20 x that seen in batch culture. The maximum cell number was 
transient and steady states did not occur. Subsequently to this, problems were 
encountered with the reliability of the hollow fibre after repeated steam sterilisa- 
tion. Hollow fibre bundles are also rather expensive and both process reliability 
and economy were sought by using a cheaper membrane in the form of dialysis 
tubing, this forms the basis of the work reported here. Some of this work has 
been presented to the European Society for Animal Cell Technology (ESACT) 
as a poster paper (Amos et a/., 1992) and published in Enzyme and Microbial 
Technology (Amos et a/., 1994)
1.3.3.1 Advantages of Dialysis Culture in Homogeneous Reactors
Dialysis culture offers the following advantages over batch and other forms of 
perfusion culture.
1. Dialysis culture supports increased cell numbers over simple batch culture, 
for extended periods of time.
2. Nutrient and cell concentrations can be modeled.
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3. Unlike heterogeneous systems, the system can be easily scaled up. Scaleabil- 
ity to 1000 litres has been demonstrated.
4. Unlike most homogeneous systems and some of the more easily scalable 
heterogeneous systems, for example macroporous microcarriers and gel bead 
entrapment), antibody is retained and is therefore recovered at very much 
higher concentrations, easing purification.
5. As only low molecular weight components need to be recirculated medium 
costs are reduced in comparison with systems that do not retain high molec- 
ular weight species
6. Dialysis culture can be conducted in ordinary reactors and no special equip- 
ment is needed. Nor is expensive consumables, such as macroporous mi- 
crocarriers, or technically difficult processes such as gel bead formation, or 
encapsulation involved.
7- Culture homogeneity allows simple global control of the reactor and rep- 
resentative sampling as well as assessment of the physiological state of the 
cells.
8. Easy access to the biomass and the relatively simple technology will ease 
process validation which is a substantial cost burden in the production of 
pharmaceuticals.
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1.4 Aims
The importance of animal cell culture in producing a wide variety of protein 
products has been explained. Dialysis bioreactors have been shown to be excellent 
bioreactors for the growth of animal cells. The theoretical advantages of membrane 
retained devices lie in their ability to accumulate product to high concentration 
and in savings in serum usage. However little is known about the physiology of 
cells in such devices, the fate of serum components and the effects on the product 
of spending an extended period in the culture medium at 37° C.
The aims of this project are to develop a dialysis culture device and use it to 
understand how cells were affected by long periods at steady state in terms of:
1. What controls cell concentration in such device?
2. What controls the level of cell viability, rate of cell death, in such a system.
3. What is the fate of high molecular weight components of the medium.
4. How is the product effected by long periods of time in, in some cases, low 
viability cultures.
Chapter 2
Materials And Methods
2.1 Cell Line and Culture Conditions
TBC3 is a mouse-mouse, NSl-derived hybridoma cell, a subclone of WC2 which 
produces antibody to the C2 region of human IgG (JefFeries et a/., 1982). PQXB1 
is a mouse-mouse hybridoma derived from the X63 653 myeloma, producing Mab 
to paraquat and was donated by Mr. Andrew Dinsmore (ICI plc.-Pharmaceuticals 
Division.) CHO-K320 cell line is a dihydrofolate reductase (DHFR) deficient mu- 
tant of CHO-K1, and was kindly provided by Wellcome Biotechnology (Becken- 
ham, Kent). Human interferon-7 is expressed. The gene was inserted using a 
plasmid vector derived from pSV2-dhfr, using the SV40 early promoter, coam- 
plified with DHFR by methotrexate selection. SF9 is an insect cell line from 
Spodoptera frugiperda, the fall army worm. It was provided by the Department 
of Cancer Studies of the University of Birmingham. A recombinant Autographa 
californica nuclear polyhedrosis virus (AcNPV) expressing the Escherichia coli 
lacZ gene for the production of /9-galactosidase was used to infect the cells. It
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was constructed by homologous recombination of the E2 clone of AcNPV and the 
plasmid pAc360 and was provided by Luckow and Summers.
2.1.1 Routine Cell Maintenance
1. Cells from 2 or 3 day old 10ml or 50ml flasks were counted.
2. Details of cell line, passage no., cell no., viability, culture volume, pH and 
additional comments if necessary were logged on a data sheet.
3. About IxlO5 cells ml" 1 were inoculated into fresh 10ml or 50ml flasks e.g. 
from a flask containing 5xl05 cells ml" 1
4. In a sterile flow cabinet 2ml of spent medium was withdrawn with a sterile 
pipette, ensuring that cells were washed from the surface of the flask by 
pulsing or scraping with a pipette.
5. 8ml of prewarmed, prepared medium was added to dilute cells back to ap- 
proximately IxlO5 cells ml" 1 . The flask was labelled with: name, cell type, 
passage no., date and media supplements (if used).
6. Cells were counted again on days 2 and 3. On day 3 cells were diluted back 
to IxlO5 cells ml" 1 . Details were entered on a log sheet each time the cell 
lines were passaged or expanded to larger volumes.
2.1.2 Cell Counting
1. O.lml of sample was taken, added to a microwell and diluted 2 fold with 
O.lml of trypan blue stain. The sample was mixed well by pulsing with a 
pipette about 10 times.
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2. Diluted samples were added to both sides of the haemocytometer slide.
3. Both sides were counted, as 2 samples, ensuring that there were no air 
bubbles present or that the coverslip was drying, before and after counting. 
All cells that overlap the 3 tramlines on the top and right sides were counted, 
those on the bottom and left not. Each grid has a volume of 0.001 ml.
4. Depending on the number of grids counted, the sample was multiplied by 
the appropriate dilution factor. 3 or 5 grids were usually counted. The more 
grids counted, the greater the accuracy.
5. Calculation of cell concentrations: The procedure was repeated 4-8 times 
to obtain an average cell count in cells ml" 1 .
Cell Count=(No. of Cells/5)x2 x 1000
N.B. Stained cells were noted as non viable cells. Only structures larger than 
a cells nucleus was counted. "Minicells" or stained blue fragments smaller 
than this were not counted as cells.
2.1.3 Cell Growth in Stirred Bottles
1. Only if the viability of the cells was high i.e. above 90-95%, were cells used 
for experiments. 50ml of cells at 5xl05 cells ml" 1 was taken and added to a 
sterile 250 or 500ml Duran bottle (Schott, England) containing a magnetic 
follower.
2. Cells were diluted up to the 200ml mark with fresh prewarmed medium 
ensuring that the pH was about 7.0 and then placed in a 37°C incubator.
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3. To expand to 800ml, 200ml of cells was placed into a 1 litre heat-sterilised 
Duran bottle and prewarmed medium added to the 800ml mark. The bot- 
tle was placed in a 37°C incubator with the magneticfollowers stirring at 
lOOrpm.
2.1.4 Freezing Cells
1. When cells had grown to 5xl05 cells ml" 1 in 50ml flasks, they were put in 
2 x 25ml vials and centrifuged at lOOOrpm for 5min.
2. The cell pellet was resuspended in freezing mixture to give a cell concen- 
tration of IxlO7 cells ml" 1 . 0.5ml of freezing mixture was placed into each 
cryotube (Nunc-Gibco), then labelled with code, cell type, viability, concen- 
tration and date.
3. Cryotubes were placed on to stage 1 of a cryogenic unit containing liquid 
N2 for 15 min.
4. Cryotubes were then moved to stage 2 for 45 min to 1 hour. When frozen 
they were transferred to a nitrogen Dewar Flask containing liquid N2, 10 
XT (Jencons Scientific Ltd.).
5. Details of frozen cell sample were entered into the log book, i.e. date, cell 
line, concentration, viability, passage no. and name.
2.1.5 Thawing Cells
1. Medium with 10% FCS in a 20ml Sterilin vial was warmed to 37°C.
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2. A cryotube of frozen cells was removed and warmed up in a 37°C water bath 
as fast as possible. The withdrawal was noted in the log book.
3. The contents of the cryotube were decanted into the universal of prewarmed 
medium.
4. The tube was mixed, a sample removed to count cells, and the rest cen- 
trifuged at lOOOrpm for 5 min.
5. The medium was decanted and the pelleted cells resuspended into fresh 
medium at 1 xlO5 cells ml" 1 in a 10ml culture flask.
6. A sample was checked daily and resuspended in fresh medium if not healthy.
2.2 Routine Medium Preparation
2.2.1 Basal Medium
2.2.1.1 RPMI
50g of xlO strength powder RPMI 1640 with L-glutamine (Gibco, Paisley) was 
dissolved in 5 1 of freshly distilled deionised water. NaHCOa at 2 gl" 1 was added 
and the pH adjusted to 7.1-7.2 with 1M HC1 after the medium was completely 
dissolved. Then the medium was filter sterilised through a 2 /mi, 20 cm membrane 
filter in a 1 1 Sartorius pressure barrel into sterile bottles and stored at 4 °C.
2.2.1.2 TC100
This was used for the growth of the insect cell line, and was purchased from Gibco. 
The powder supplied by Gibco was suspended in 4.51 of distilled deionised water.
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pH was then adjusted to 5.0 with 3.5M HC1. When it was o completely dissolved 
1.75g of Na HCO3 was added. Next the pH was readjusted to 6.2 with 1M NaOH 
and the volume was made up to 51 with distilled deionised water
2.2.2 Media Supplements
2.2.2.1 Serum
500ml of sterile Foetal Calf Serum (FCS; GIBCO, Paisley), or Newborn Calf 
Serum (NBS; Advanced Protein Products, West Midlands) was dispensed into 
25ml aliquots and frozen at   20° C. At least 2 days before use the complete 
medium of RPMI 1640 supplemented with 5% v/v of serum was made up. 25ml 
of frozen FCS or NBS was thawed and added to 500ml basal RPMI 1640. A 1ml 
sample was placed on an agar plate and 10ml removed into a Sterilin tube to 
incubate at 37°C to test for contaminants.
2.2.2.2 Pluronic F-68 - 0.125% (v/v)
1.25 grams of Pluronic F-68 (BASF, Germany) was dissolved in one litre of RPMI 
1640 medium, and sterile filtered.
2.2.2.3 Freezing Mixture
FCS and 8.8% Dimethyl sulphoxide (DMSO) i.e. 20.7ml FCS and 2ml DMSO. 
The mixture was divided into 4ml aliquots.
2.2.2.4 Trypan Blue
5g trypan blue (Sigma, Poole) was dissolved in 100 ml distilled water.
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2.2.2.5 Peptone and Biopro
Was added at the required concentration to RPMI and then sterile filtered.
2.3 Culture Vessel
2.3.1 Reactor Description
A 21 capacity, unbafned, hemispherical bottom, top driven, glass bioreactor of ves- 
sel diameter 0.12m, kindly loaned by Setric Genie Industriel (Toulouse, France) 
was used. One 4-bladed, 45° pitch impeller (D=0.06m) of width 70mm was 
mounted 0.115m from the headplate for agitation. Headspace aeration at 100ml 
min" 1 with agitation at lOOrpm (the maximum rate) was sufficient for O? sup- 
ply to a batch culture without the need for sparging. For high density cultures 
pure oxygen was used either sparged or via 1 metre of thin walled silicone tubing 
suspended within the liquid. The air/C02 mixture was controlled by automatic 
solenoid valves. Flow rates of the gases were controlled by needle valves, the sup- 
ply of C02 being turned on if the pH rose above the set point, the supply of 02 
turned on if the dissolved oxygen tension fell.
2.3.2 Preparation
The following calibrations were necessary before use:-
1. The Ingold pH probe was calibrated with buffer solutions following the man- 
ufacturer's procedure.
2. The temperature probe was calibrated at 37°C against a mercury thermome- 
ter and the temperature was set to control at 37°C by an air jacket.
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3. The indicated speed on the meter of the motor drive of the bioreactor was 
calibrated against the running speed with a TM 2011 electronic tachometer 
(Anders Ltd., London).
4. The DOT probe (Ingold) was calibrated by sparging air then nitrogen thr- 
ough distilled water at 37°C, placing the probe in it and setting zero and 
span.
Before use, the vessel was soaked overnight in Triton 7X solution (Flow Labs.), 
following which the vessel, probes and pipes were thoroughly washed with distilled 
water. The ports were covered with metal foil and autoclave tape and the vessel 
autoclaved at 121°C for 20-25min. After sterilisation the vessel was mounted on 
the drive unit and the instruments connected to the controllers.
The inoculum and medium, prewarmed to 37°C, 1 litre in volume, were mixed 
in a laminar air flow cabinet, put in an inoculation bottle and brought top the 
reactor. Therperature pH and DOT usually reached set point values within an 
hour. Each sample was taken in a 25ml Me Cartney bottle, which was then 
replaced by a fresh sterile bottle after flaming its top.
2.3.3 Dialysis Mode Description
Figure 7 is a schematic diagram of the reactor used for this study. TBC3, was 
grown in homogeneous suspension culture in a standard SETRIC 2 litre Animal 
Cell Fermenter (Setric Genie Industriel (France)). pH was controlled at 7.0, au- 
tomatically, by C02 addition, and the dissolved oxygen concentration was main- 
tained at 50% air saturation by sparging with pure oxygen. 370 cm2 of visking 
tubing (10 cm diameter) was suspended in the fermenter, in a coiled configuration,
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supported by thick copper wire, acting as a shapeable former. The wire was sealed 
in silicone tubing, and this was threaded through the dialysis tubing. Medium, 
without serum, was circulated from a reservoir through the dialysis tubing. The 
reservoir was replenished constantly with fresh medium, the excess being forced 
by air pressure to a waste reservoir.
2.3.4 Continuous Culture
A 500 ml duran bottle was modified with ports for continuous culture. The culture 
volume was maintained at 300 ml by positive pressure from a 5% CO2 in air supply. 
The reactor was placed in a 37 °C waterbath.
2.4 Assays
2.4.1 Glucose Assay
Glucose levels were measured using a glucose strip test kit (Boehringer-Mannheim). 
A drop of supernatant was placed on a test strip, left for 60 sec. and dried with a 
tissue. The strip was placed into the reader and after another 60 sec. the glucose 
level was displayed. The glucose readings were calibrated with standard solutions 
ranging from 0.2-2.5 g I" 1 .
2.4.2 ELISA
The principle of the sandwich type ELISA is the formation of several layers of 
molecules, one attached to another in a single row, the last molecule being a 
reactive substrate which yields a yellow colour on reaction. Initially, antigen
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Figure 7: Schematic Diagram of Dialysis Reactor
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(Human IgG) is added to bind to the surface of a well and when the supernatant 
containing mouse anti-human antibodies is added they bind to the Human IgG. 
Next casein solution is added to block all remaining binding sites. Then sheep 
anti-mouse IgG, with a peroxidase molecule, is added as the third layer of the 
sandwich to bind to the mouse antibody. Finally the citric acid substrate is added, 
forming the fourth layer, which reacts with the peroxidase molecules resulting in 
a yellow colouration. The intensity of the yellow colour is an indication of the 
concentration of mouse IgG attached to the wells.
Solutions (all chemicals were purchased from Sigma, Poole).
1. Coating Buffer - 0.05M Carbonate buifer pH 9.6. 0.795g Na2 C03 and 1.465g 
NaHCOs were dissolved in 500ml of distilled water. This was sufficient for 
40 plates.
2. Washing Buffer A - Phosphate Buffered Saline (PBS) lOx stock solution pH 
7.4. 400g NaCl, lOg K H2P04, 144.6g Na2HP04 .12#2 O, and lOg KC1 were 
dissolved in 5 1 of distilled water, and the pH adjusted with HC1 or NaOH 
to 7.4. Working strength Buffer A 1 1 of 10 x solution was added to 9 1 of 
distilled water.
3. Washing Buffer B - Working strength Buffer A with 0.05% Tween 20. 2.5ml 
of Tween 20 was added to 5 1 of PBS.
4. Blocking Buffer - 2% Casein. 2g casein was added to 11 PBS, stirred at 37°C 
(for 4 hours to dissolve) and stored frozen in 25ml aliquots in universals. One 
universal was used per plate.
5. Diluting Buffer - 0.525ml of 2% casein was diluted in 75ml of PBS.
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6. Substrate solution citrate and phosphate buffer. Two solutions were made 
up as follows:- A 0.1M Citric acid - 10. 5g in 500ml distilled water. B 0.2M 
Na2HPO4 . 12#2 0 17.8g in 500ml distilled water. Fresh substrate solution 
sufficient for 2 plates was prepared:- 8mg of 0-phenylene diamine (OPD), 8 
H\ of H202, and 12ml of A were added to 8ml of B. The pH was adjusted to 
4.3-4.4 with NaOH and the solution stored in the dark.
7. Stopping solution 12.5% HzSO*. 12.5ml of concentrated H2S04 was added 
to 100ml of distilled water.
Method
Samples for analysis, standards, antigen, conjugate and 2% casein, which were 
stored frozen at -20 C, were thawed out before starting work. Solutions for ELISA 
were prepared in advance.
1. Human IgG, 2mg ml" 1 in PBS (Sigma) was diluted to 2.5 fil ml" 1 in coating 
buffer. A 50 /zl aliquot of Human IgG was added to 20ml of coating buffer 
(enough for 2 plates) and then 100 fA was applied to each microtitre well. 
The plate was covered with cling film and the antigen Human IgG was left 
to bind at 4 C overnight.
2. The plate was bang dried, then 100 {A of 2% casein in blocking buffer was 
added to each well and incubated at 37° C for 1 hour to eliminate the re- 
maining binding sites on the plastic plate.
3. The plate was washed 4 times with buffer B and bang dried.
4. The standard primary antibody and test samples were added next.
a) Sample preparation:- 100 //I of sample was added to 900 //I of PBS and
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0.05% casein and mixed well, to give a 1 in 10 dilution. This step was re- 
peated to give a 1 in 100 dilution. At least duplicate samples were taken, 
preferably quadruplicate samples for accurate readings, 
b) Monoclonal antibody standard preparation:- 3 vials of 10 //I frozen stan- 
dards were taken and Iml of PBS and 0.05% casein was added to each vial 
to make a concentration of lOOng ml" 1 . Standards of 70, 60, 50, 40, 30, 20, 
10 and 5ng ml" 1 were made by diluting as follows:-
Stds. (iig/ml) Mab(ul) PBS+0.05'/,casein 
70 70 30
60
50
40
30
20
10
5
60
50
40
30
20
10
5
40
50
60
70
80
90
95
5. 1 set of 8 standards (100 /*! per well) was applied on row 2 and another on 
row 11 of the plate and 100 pi of PBS and 0.05% casein were added to the 
remaining wells. Rows 1 and 12 were kept as blanks.
6. One set of 8 samples was placed on row 3. This gave a 1 in 200 dilution of 
the initial concentrations. The culture was mixed well and 100 //I of samples 
transferred to row 4 to give a 1 in 400 dilution; then 100 //I was transferred 
from row 4 to row 5 for a 1 in 800 dilution and finally 100 n\ transferred 
from row 5 to row 6 for a 1 in 1600 dilution.
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7. This procedure was repeated moving from row 7 to row 10 to give a duplicate 
set of readings.
8. The plate was covered with metal foil and incubated at 37° C for 45 minutes. 
After this the plate was banged dry and washed 3 times with buffer B to 
remove the excess unbound antibodies.
9. The secondary antibody - conjugate was applied next. Conjugate: Sheep 
anti-mouse conjugated to horseradish peroxidase samples were frozen in 10 
fjl aliquots. 2 vials of 10 /A of conjugate were taken and 20ml of PBS with 
0.05% casein was added to them. This was sufficient for 2 plates. 100 /// of 
conjugate was added per well, the plate covered with foil and then incubated 
at room temperature for 45 min.
10. The plate was washed 6 times with buffer B and bang dried.
11. 100 ill of fresh citrate-phosphate substrate solution was added to each well 
and the plate covered with foil. This was incubated in the dark at room 
temperature until the 5ng standard started to show an increased orange 
colour over a blank well. Alternatively the plate was checked after 15min of 
incubation and the reaction stopped.
12. The reaction was stopped with 50 fA of 12.5% H2S04 and the absorbance 
read on the ELISA plate reader at 492nm after blanking on an empty well. 
Plates were frozen if there was no time to read them.
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2.4.2.1 ELISA for PQXBl
The same general technique was used, except that the plate was coated with Sheep 
anti mouse IgG. The assay therefore measures antibody protein concentration, not 
binding activity.
2.4.2.2 Interferon-7 ELISA
The same procedure was followed as in the IgG ELISA. Polyclonal anti human 
7 interferon serum was bound to the plate, then used to capture the test sam- 
ples and standards (Sigma). Monoclonal anti-interferon-7 serum formed the next 
layer of the sandwich, and finally goat anti mouse serum (Sigma) conjugated to 
horseradish peroxidase. The anti-interferon monoclonal and polyclonal antibodies 
were a gift from Dr N. Jenkins of the University of Kent at Canterbury, U.K.
2.4.3 /3-galactosidase Assay
Reagents Z-bufFer: 0.01M K Cl, 0.06M Na2 HPO4 , 0.04M NaH2P04 , 0.01M 
Mg 864. 0.05M 2-mercaptoethanol. Initiator: 4 mg ml" 1 2-nitrophenol-/3-D- 
galactopyranoside (ONPG) in Z-bufFer. Stop Solution: 1M Na2 COa.
Method
1. The samples were diluted ten fold in 10 Z-bufFer and 200 fi was applied to 
each well.
2. The samples were diluted, using doubling dilution down the plate, leaving 
100 IJL\ in each well.
3. 20 //I of Initiator was added and the sample incubated at 28°C for 30 minutes.
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4. 100 fA of Stop solution was added.
5. The plate was read in a spectrophotometer at 415 nm
6. /?-galactosidase activity- OD^0 xdiiutionxo^2(ii9htpath) Jn Internationai Units 
ml" 1 .
2.4.4 Lactic Acid Assay
Reagents lOmg of nicotinamide adenine dinucleotide (NAD); 2ml of glycine buffer; 
4ml of distilled water and 0.2ml of lactate dehydrogenase were combined in a 25ml 
universal container. 
Method
1. 0.98ml of reaction mixture was put in a 2ml cuvette and to this was added 
16 /zl of cell-free supernatant.
2. All samples were covered with cling film and incubated at 37°C for 30 min.
3. Lactic acid standards of 3, 6, 12, 20 and 25mM were made up and incubated 
at 37° C for 30 min.
4. The spectrophotometer was set to 340nm, and allowed to warm up for 30min.
5. After 30 min. cuvettes were removed from the incubator and the absorbance 
read after blanking on a cuvette with no supernatant.
6. Standards were plotted on a graph against the absorbance readings and 
sample concentrations determined from this calibration curve.
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2.4.5 Ammonia Determination
From Fawcett and Scott (1960) 
Reagents
A) 250 g Phenol, 1.35g Sodium Nitroprusside. Make up to 4.5 1 with distilled 
water.
B) 132 ml 3.3M Sodium Hypochlorite, make up to 4 1 with distilled water. To 
80g Na OH add solution to make 4 1. The reagents are light sensitive, but store 
indefinitely in dark. Method
To 40 fi\ of sample (0-2mM) one ml of reagent A was added then one ml of 
reagent B, then mixed well. After incubation at 37° C for 15 minutes in the dark 
the extinction was read at 570 nm against air.
2.4.6 3H Thymidine Incorporation
Reagents
Thymidine cocktail (ImCi ml" 1 ) 25 //I of non-radioactive Thymidine at (10 //g 
ml' 1 ) with 100 fA of 3H Thymidine (ImCi) and 875 fil of PBS. 10% Trichloroacetic 
Acid (TCA), 5% TCA, 95% ethanol and scintillation fluid, Optiphase X (LKB, 
Loughborough). Method
1. Cells were counted, then the sample concentrated or diluted to 5xl05 cells 
ml" 1 . 5ml of this cell concentration was placed into a universal tube. This 
procedure was repeated to give duplicate or triplicate samples.
2. 5 fj,\ of Thymidine cocktail was added to each tube to a final 3H thymidine 
concentration of ImCi ml" 1 and incubated at 37°C in a C02 incubator for 
30 min.
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3. Glass fibre filters (Whatmann GF/C) or 0.45 //m filters (Millipore) were 
placed on a Millipore vacuum filter.
4. Samples were filtered and washed twice with PBS.
5. Samples were washed with 10% TCA to precipitate the protein, then washed 
with 5% TCA and finally with 95% ethanol.
6. The filter was removed with a pair of pincers to dry in a scintillation tube. 
This was labelled and stored.
7. 10ml of Optiphase X was added to each sample tube and 10ml to a blank. 
Samples were taken to a Mk III scintillation counter for reading.
2.4.7 Flow Cytometry
Cells were analysed using a Coulter Elite flow cytometer (Coulter Instruments, 
Luton).
All samples were counted, then either resuspended in cold 70% ethanol at 
IxlO6 cells ml" 1 and stored at 4°C for at least 30 minutes prior to staining, or 
treated with DNase.
2.4.7.1 DNase Treatment
The DNA content of dead cells does not necessarily reflect the current status of 
live cells. DNase is able to penetrate only dead cells. It can therefore be used to 
remove DNA from these cells, removing them from the analysis.
1. DNase II (Sigma) suspended in a Sucrose Magnesium and Tris buffer (800 
ml H 2 0, 2.43g Tris adjust pH to 6.5 with 1 M HC1, add 85.6g Sucrose and
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l.OIGg Magnesium, make up to 1 litre). Add 100 mg of DNase II (Sigma) 
to 200 ml SMT solution, store in 1ml aliquots at -20°C.
2. 5xl05 cells ml" 1 of sample was placed in a test tube and spun down at 1000 
rpm for five minutes, after which the supernatent was discarded.
3. The cells were resuspended in 1 ml of DNase solution and incubated at 37°C 
for 30 minutes then spun down.
4. The cells were resuspended in cold 70% ethanol and stored at 4°C for at 
least 30 minutes prior to staining.
2.4.7.2 Propidium Iodide Staining
Propidium Iodide (PI) intercalates with two stranded nucleic acid. Upon exci- 
tation, which occurs at a maximum at 536nm, it emits fluorescence at 617 nm. 
Excitation of fluorescence can be achieved with an argon laser which emits light 
at 488nm (blue). It can be used to analyse the cell cycle status of a population of 
cells. Accuracy may be improved by prior removal of RNA, some of which is two 
stranded, using RNase.
1. 1ml of cells at IxlO6 cells ml"1 were washed in PBS. Then resuspended in 
a solution of RNase in PBS, and incubated for 30 minutes at 3°C.
2. Resuspend in 1 ml PBS.
3. Add 76/^1 of 650//g ml" 1 Propidium Iodide in PBS. Incubate for 10 minutes 
at room temperature.
4. Resuspend in PBS.
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2.4.8 SDS Polyacrylamide Gel Electrophoresis
Proteins when placed in a high pH buffer have a net positive charge. This fact may 
utilised in gel electrophoresis to separate proteins on the basis of their molecular 
mass. In gradient gel electrophoresis proteins in a buffer solution migrate through 
a gel of an increasing degree of crosslinking, driven by an electric charge, until 
the pore size of the gel is smaller than the size of the protein. Sodium dodecyl 
sulphate denatures the proteins, removing effects caused by differences in shape. 
Reagents.
1. Sample buffer, lOmM Tris-HCl pH 6.0: l.Og Tris + 40 ml H2 0 + HC1 to pH 
6.0 add H2 0 to 100 ml. Add 2.5g SDS and 10 mg of Bromophenol Blue.
2. Stacking buffer stock: 0.5 M Tris-HCl, pH 6.0: 6.0g Tris + 40 ml H2 0 + 
HC1 to pH 6.0, approx 48 ml 1.0 M , add H2 0 to 100 ml.
3. Resolving buffer stock: 3.0 M Tris-HCl, pH 8.8: 36.3g Tris + 48 ml 1.0 M 
HC1 add H20 to 100 ml.
4. Reservoir Buffer stock: 0.25 M Tris-HCl, pH 8.3 (lOx stock): 30.0g Tris, 
144.0g glyine in 1 litre. Adjust to pH 8.3 with 1.0 M HC1.
5. Acrylamide-bis: 30% acrylamide, 0.8% methylene-bis acrylamide: 30.Og 
acrylamide, 0.8g methylene-bis acrylamide, add H2 O to 100 ml.
6. SDS: 10% sodium dodecyl sulphate: lOg SDS, add H2 0 to 100 ml.
The acrylamide solution was made up fresh each time a gel was prepared, the 
other solutions were stored. Table 3 shows the composition of the gels used.
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Table 3: The composition of the reagents for the 6%-18% acrylamide gel
Acrylamide-bis (ml) 
Resolving buffer (ml) 
10 water (ml) 
Sucrose (g) 
TEMED (fi\)
Sealing Gel Resolving Gel Stacking Gel 
6% 18%
4.0 
0.75 
1.05
5
2.4 7.2 
1.5 1.5 
7.7 1.9 
1.8 
5 5
1.2 
2.5 
5.65
7.5
2.4.8.1 Gel Preparation
Two 1.5 ml thick perspex spacers were lightly coated with vaseline, and placed 
parallel at either end of a sheet of clean glass. Another sheet was placed on top 
and the sandwich was clamped together. The gel plates were placed vertically in 
a small reservoir and 10 ml of blocking gel solution was poured in the reservoir. 
When the blocking gel had set, the resolving gel was poured in from the top and 
finally the stacking gel added.
2.4.8.2 Sample Preparation
To 20 //I of culture supernatent 10/zl of 10% SDS solution was added after which 
the samples were placed in an oil bath at 4°C for 10 minutes. The same treatment 
was applied to the standards (Sigma).
2.4.8.3 Running the Gel
The gel and plates were placed in a vertical electrophoresis tank and reservoir 
buffer was placed in both top and bottom reservoirs. 50 mA was applied across 
the gel overnight or until the dye front had reached the end of the gel.
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2.4.9 Western Blotting
Gel Electrophoresis is a powerful technique for protein separation, but in many 
cases the proper identification of a protein separated by this technique is also 
best achieved by stains with a high molecular weight, such as antibody and there- 
fore limited mobility in the gel. Western blotting gets around this problem by 
transferring protein from the gel to the surface of a paper matrix, which is then 
easily accessed by high molecular weight stains. Transfer is encouraged by ap- 
plying an electric field width-ways across the gel and blotting paper through a 
high pH solvent. In this case the protein was detected using the same anti-mouse 
polyclonal serum conjugated to horse radish peroxidase as is used in the TBC3 
ELISA, together with a similar colourimetric reaction. 
Reagents:
Buffer: 
H2 02 (30%) 10//1
H 2 O 15 ml 
Stain: 
Tris HC1 (0.1M) pH 7.2 12 ml
4,3 diaminobenzidine 4 HC1 (0.5% in Tris HC1 3ml
Ni Cl 6H2 0 (8% w/v) 150 fil 
Method
A piece of the membrane material, Poly vinylidene difluoride (PVDF) (Millipore, 
Watford, UK), was cut to the same size as the gel, along with two pieces of ordinary 
ink blotting paper. These were soaked in blotting buffer. The gel, membrane 
and blotting paper were arranged on the flat graphite electrode surfaces of an 
electroblotter (Biorad, Hemel Hempsted, UK.) carefully to avoid trapping any air 
between the layers (see Figure 8). An electric current of 50 mA was applied across
CHAPTER 2. MATERIALS AND METHODS 53
Figure 8: Schematic diagram of the arrangement of layers in the Western Blot.
Cathode 
Blotting Paper
Gel
Membrane 
Blotting Paper 
Anode
the sandwich for 2 hours.
The membrane was incubated in a solution of 3% ovalbumin in PBS, to remove 
remaining protein binding sites. It was washed in PBS, then incubated with poly- 
clonal anti-mouse IgG-HRP conjugate diluted in a PBS. It was washed with PBS 
3 times for 5 minutes each, then dipped in the substrate solution until sufficient 
colour had developed, where-upon the reaction was stopped by washing in PBS.
Chapter 3
Experimental Programme
Cell lines differ from each other in their requirements for serum, rate of use of basal 
medium components, sensitivity to toxic metabolites, specific production rates, 
etc. This is particularly true of hybridomas which can have order of magnitude 
differences in specific antibody production rate for example. This laboratory 
has had considerable experience with hybridorna cell lines. Antibodies are stable 
products, which the laboratory had assays set up for. Therefore two hybridorna 
cell lines were chosen to asses their suitability for use in dialysis culture. Batch 
cultures were performed on these cell lines. The results of these batch cultures also 
formed a basis for comparison with dialysis cultures (see Problems in comparing 
systems, Page 15).
Ammonia and lactate are both toxic by-products of metabolism, which have 
been shown to limit the growth of cells in culture (Hassell et a/., 1991). The 
sensitivity of cells to them varies according to the cell line used (Hassell et a/., 
1987). The sensitivity of TBC3 to both was identified using exogenously added 
lactate or ammonia in batch culture.
54
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Two complex, undefined, nutrient sources were compared for their ability to 
increase cell growth, as both hybridorna lines proved rather low yielding.
To test their suitability under dialysis conditions both cell lines were grown 
in dialysis culture in small bottles. These devices were simple to construct and 
operate and were cheap to run. Few differences were observed between the two 
cell lines, so TBC3 was chosen for further examination as it was the one with 
which we had the greatest previous experience.
After successful growth in small bottles, more constant environmental condi- 
tions were sought by using a pH and DOT controlled bioreactor. Changing from 
a batch reservoir to a continuous reservoir system also helped to keep the environ- 
ment constant. Steady state cell concentrations were observed to occur at a range 
of different membrane areas. The systems seemed to be limited by membrane 
area.
As the reactor was limited by membrane area and, since the mathematical 
models of Hagerdorn and Kargi, and Schultz and Gerhardt were available, though 
neither were fully applicable it was decided to develop our own model. This would 
allow the characterisation of performance with a view to identifying key process 
variables and provide a means of experimentally characterising the membrane and 
predicting the cell mass, nutrient and toxin concentrations.
The next stage was to verify the model experimentally. This was done by 
noting the cell, nutrient and toxin concentrations at a variety of fresh feed flow 
rates. This experiment was repeated for a second membrane area.
Serum must, normally, be added to the medium to allow cell growth. Due to 
the presence of a membrane it can be divided into two parts, that which can pass 
through the membrane and that which cannot. The importance of both parts
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needed to be identified, as the lack of a continuous addition of fresh serum is a 
major difference between dialysis culture and other forms of perfusion culture. 
To see the effect of removing the low molecular weight components of the serum 
under batch conditions, cells were grown in dialysed serum. High molecular weight 
components of serum are retained within the reactor and may be deactivated by 
the conditions experienced. Periodic shots of serum were added to a reactor 
at steady state. The increases in cell number observed were accompanied by 
changes in glucose concentration. This suggested that glucose was the limiting 
nutrient. The experiment was then repeated with a higher glucose concentration, 
with continuous addition of serum.
Cell specific productivity has been shown to alter according to the physiologic 
state of the cell. Most types of membrane-based, total cell retention perfusion 
devices produce heterogeneous conditions, some making representative sampling 
of the biomass difficult. This device does neither. Cell size and cell turnover rates 
were determined for this system, as both affect specific productivity.
Chinese Hamster Ovary (CHO) cells are extensively used for the production 
of recombinant proteins. They have a higher cell yield on medium than the hy- 
bridoma cell we were using, and they are not susceptible to apoptosis (Singh et a/., 
1994a). Interferon-7 is a commercially important product. Since, in other reports 
of dialysis culture eg (Schlaegar and Schumpp, 1992; Szperalski et a/., 1994) steady 
state cell viabilities are higher than with TBC3 it was decided to grow CHO in 
dialysis culture.
The virus Autographa californica nuclear polyhedrosis is a member of the bac- 
ulovirus group. It has a gene expressed late in its lytic cycle, which is not essential 
to viral replication, which is expressed at very high levels producing up to 50% of
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the total cell protein as its product, the polyhedrin protein (Cameron et a/., 1988). 
This virus has been used as the basis for a number of very effective expression 
vectors. The virus is normally added to cultures of insect cells midway through 
the exponential growth phase of a batch culture, as this produces the highest to- 
tal yield. However a number of recent articles suggest that this is due to lack of 
nutrients for further production. Replacing the medium with fresh when the cells 
have reached the maximum cell density of a batch culture gives much higher spe- 
cific productivity. Replacement of medium by a variety of perfusion cultures has 
been attempted, but, as Insect cells require expensive foetal calf serum, or equally 
expensive serum free formulations, this is an expensive option. Replacement of 
nutrients using dialysis allows cheaper basal medium to be used. A comparative 
experiment was attempted by growing a culture to maximum cell density, infect- 
ing it with virus, and then splitting it between two reactors, one dialysed, the 
other not.
Chapter 4
Experiments
4.1 Choosing a Hybridoma
For the work described in this section batch and small scale dialysis cultures were 
conducted. The purpose of the batch cultures was to develop familiarity with 
the cell line and equipment and to act as a basis for comparison with dialysis 
culture. Two cell lines were compared using both modes. As discussed in the 
introduction (Section 1.2.3) hybridoma clones can be very different from each 
other physiologically. Here we tested for gross differences in the cell line under 
dialysis conditions.
4.1.1 Batch Cultures
Figure 9 shows a typical batch culture of TBC3 in a pH and DOT controlled 
reactor (pH 7.0, DOT=50%). It was inoculated at 0.2xl06 cells ml" 1 , as a 10% 
volume inoculum, into RPMI 1640 with 5% NBS. A maximum cell density of 
0.78xl06 cells ml" 1 was achieved after 51 hours, and there was no stationary
58
CHAPTER 4. EXPERIMENTS 59
Table 4: Comparison of the growth of TBC3 and PQX/B1 in batch culture
Max Cell Cone. xlO6 cells ml" 1 
Viability Index xlO6 cells ml^hr"1 
Max Antibody Cone, //g ml" 1
TBC3
0.78 
42.3 
45
PQX/B1
0.72 
34.5 
35
phase, the cell concentration decreasing from 0.78xl06 cells ml 1 to 0.22xl06 
cells ml" 1 in 72 hours. Viability Index, which is the total number of cell hours, 
was 42.3 x 106 cells ral^hr"1 . It was calculated by taking the average of successive 
cell counts, multiplying this by the time interval between the counts, then taking 
the sum of all such measurements over the whole fermentation.
\r wt T A Viability Index =
Glucose was totally consumed reaching zero during the decline phase. Lactate 
and ammonia were produced (figure 10). Antibody was produced in all phases of 
the batch growth, the final concentration being 45 //g ml" 1 .
Figure 11 shows a typical batch fermentation of PQX/B1 in a pH and DOT 
controlled reactor(pH 7.0, DOT=50%). It was inoculated at 0.1 xlO6 cells ml" 1 as 
10% inoculum in RPMI 1640 with 5% newborn calf serum (NBS). A maximum cell 
density of 0.72xl06 cells ml" 1 was achieved after 58 hours, and again there was 
no stationary phase, the cell concentration decreasing from 0.72xl06 cells ml" 1 
to 0.22xl06 cells ml" 1 by 96 hours. Viability Index was 34.5 xlO6 cells ml^hr" 1 . 
Glucose was also again totally consumed reaching zero during the decline phase. 
Antibody was produced in all phases of the batch growth, the final concentration 
being 35 //g ml" 1 . Table 4 compares the two fermentations
CHAPTER 4. EXPERIMENTS 60
o
z
"3
O
O
0 20 40 60
Time (hrs)
80 100
O
Figure 9: Batch growth of TBC3 (pH 7.0, DOT 50%, lOOrpm, 10% inoculum vol- 
ume, RPMl 1640 and 5% NBS). Cell Concentration (Q), Antibody Concentration
(O).
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Figure 10: Metabolic profile of TBC3 batch fermentation. Glucose concentration 
(O)? Ammonia concentration (El), Lactate concentration
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Figure 11: Batch growth of PQX/Bl in (pH 7.0, DOT 50%, lOOrpm, 10% in- 
oculum volume, RPMl 1640 and 5% NBS). Cell concentration (Q), Antibody 
concentration (O), Glucose concentration
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4.1.2 Small Scale Dialysis Experiments
It was decided that some initial experiments should be performed on a small 
scale as an inexpensive means of indicating the potential of the system. The 
system of Adamson et al. (1983) was adapted by placing a 2cm section of dialysis 
tubing, filled with 5 ml of 1.5xl06 cells ml" 1 , in a 250ml duran bottle, with 
100 ml of basal medium, stirred with a magnetic flea. After 5 days the tube was 
opened, and the internal cell concentration found to be 9.6xl06 cells ml" 1 , at 86% 
viability. Dialysis was therefore capable of supporting high cell densities. Rookes 
et al. (1989) in this laboratory had previously grown TBC3 in a homogeneous 
dialysis system using suspended hollow fibre units. These units were expensive, 
would not stand repeated re-autoclaving and did not prove sufficiently reliable. 
Dialysis tubing was chosen as a cheap and simple alternative. Initial experiments 
were performed in small, magnetically stirred bottles. A 150 ml duran bottle 
was used at a volume of 50 ml. The lid was modified (see figure 12) to allow 
4 metal ports to be inserted into the reactor; two were for surface aeration, the 
others were connected to 30 cm2 of dialysis tubing suspended in the culture. 
500 ml of medium was recycled from the medium reservoir through the dialysis 
tubing. The entire contents of the medium reservoir were replaced periodically. 
The reactor was placed in a water bath at 37 °C and 5% C02 in air was supplied 
at 10 ml per minute. The entire system was taken to a laminar flow cabinet for 
sampling. TBC3 and PQX/B1 have performed similarly in batch growth. They 
were therefore compared in dialysis mode.
Figure 13 shows the growth of TBC3 in dialysis mode. At 49 hours the per- 
fusate was replaced with fresh basal medium. The cell concentration reaches a 
maximum of 2.5xl06 cells ml" 1 at 96 hours, dropping to 1.3xl06 cells ml" 1 by
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150 hours. Glucose concentration varied around the 0.6-0.3 g I" 1 mark. The max- 
imum cell concentration was three times that observed in batch culture and the 
system was operating for 30% more time than the batch culture before becoming 
contaminated. Glucose was not limiting and actually increased towards the end 
of the culture, due to to the supply from the nutrient reservoir. This suggests that 
the system is limited by nutrient transfer, so when glucose demand decreases the 
glucose concentration increases to balance reactor and reservoir concentrations.
In Figure 14 a PQX/B1 fermentation is shown. The medium reservoir is 
replaced at 87 hours. The cell concentration peaks at 2.4xl06 cells ml" 1 , again 
approximately three times that observed for batch culture. The culture lasts 
for 187 hours, nearly twice as long as an ordinary batch culture. Again glucose 
concentrations are not limiting and are variable between 0.9-0.4 gl"" 1
4.1.3 Discussion
In batch culture TBC3 out-performed PQX1 in all parameters: maximum cell 
concentration, viability index and final antibody concentration. PQX1 had a 
higher rate of glucose use than TBC3. Difference in growth yield on medium may 
explain the difference between the cell lines. The cell concentrations and growth 
rates seen are typical of hybridomas in batch culture.
The differences seen in the antibody concentrations may not be a fair compar- 
ison. The assay for the anti-human IgG antibody of TBC3 measures only that 
antibody which binds the antigen. PQX1 produces an antibody which binds to 
the weed-killer paraquat; the assay used measures all mouse antibody. If the an- 
tibodies are all intact and functioning these measurements should be identical. 
However if damage to the antibody occurs, then the total antibody measurements
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Figure 12: Schematic diagram of the dialysis bottle device.
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Figure 13: Dialysis Culture of TBC3 in dialysis bottle device. Cell concentration 
(O), Glucose (v), Medium change (|).
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Figure 14: Dialysis Culture of PQX/Bl in dialysis bottle device. Cell Concentra- 
tion (Q), Glucose (v), Medium change (j).
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will over-read the amount of "active" antibody.
In the dialysis bottle cultures considerable benefits over batch culture were 
seen, with a tripling of the maximum cell concentration and batches lasting twice 
as long. No significant differences were observed between TBC3 and PQX1. 
Metabolite concentrations were variable however and thus temporal changes in 
cell physiology would occur, making the system performance difficult to predict.
TBC3 was chosen to concentrate on in further work because it exhibited a 
higher yield on medium, both of cells and of antibody and also because, as dis- 
cussed above, the assay for antibody more accurately reflected the quantity of 
"useful" antibody. Finally there was more experience within this laboratory in 
handling TBC3.
4.2 Biopro as a medium additive
The reduction or elimination of the use of serum in animal cell culture is highly 
desirable because of its high cost and variability and the possible contamination 
with adventitious agents that it introduces. Most approaches involve the use of 
proteins fractioned from serum, for example albumin and transferrin and these 
are expensive. An alternative is the use of undefined protein or peptide sources. 
Peptone is an enzymatic digest of animal tissue which has been shown by several 
groups to be effective as a medium supplement increasing maximum cell numbers 
and monoclonal antibody titres. Jan (1992) has reported a doubling of TBC3 
steady state cell numbers in a spin filter perfusion system with a 0.25% w/v 
addition of peptone and a corresponding increase in antibody concentration. Al- 
Rubeai and Emery (1989) were able to grow a hybridoma culture using peptone
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and transferrin in place of serum. Peptone has been used extensively in this work.
In an attempt to explore other possibilities an investigation was made of the 
use of milk protein. Ramirez et al. (1990) grew hybridomas in bovine colostrum as 
a substitute for serum. Yamada et al. (1991) used casein as a serum additive and 
assigned its action to the slow release of amino acids from the casein by proteases 
secreted from the cell. Biopro is a preparation of milk proteins, produced by ion 
exchange chromatography, produced by Bio-Isolates Pic, Deeside, Wales. It is 
95% protein, mainly /9-lactoglobulin and a-lactalbumin, is not denatured and is 
soluble. It is used in a variety of food products because of its gelling, emulsifying 
and aeration properties.
Batch cultures were set up using 150 ml duran bottles and duplicate bottles 
were filled with 50 ml of RPMI containing either 0, 0.1, 0.25, 0.5, 0.75, or 1.0% w/v 
Biopro. The Biopro was dissolved in RPMI at the experimental concentrations 
and filtered into the bottles. The bottles were inoculated at 10% v/v at O.lxlO6 
cells ml" 1 with TBC3 taken from one source.
Table 5 shows the effect of Biopro addition on cell number. The maximum cell 
number of 0.85 x 106 cells ml"1 was achieved at 0.25% w/v, compared with 0.7 x 106 
cells ml" 1 for the control. The maximum viability index was achieved at 0.5% 
w/v, 1.3 times higher than for no addition. The maximum final antibody titre 
was 50 ng ml" 1 , achieved at 0.75 % w/v,representing an increase of 1.3x. Biopro 
does not seem to have any effect on cell specific antibody production, the increases 
in antibody concentration being proportional to the increased cell concentrations. 
For further experiments a concentration of 0.75% w/v was chosen.
If Biopro's nutritional effect is due to release of amino acids it may produce an 
improved growth even in cultures supplemented with foetal calf serum, which is
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Table 5: Effect of Biopro on batch TBC3 growth in batch culture
70
Biopro
%w/v
0
0.1
0.25
0.5
0.75
1.0
Max. Cell Density 
xlO6 cells ml- 1
0.70
0.72
0.85
0.80
0.75
0.65
Viability Index 
xlO6 cell x hours ml" 1
40.2
41.5
46.0
53.0
50.5
45.4
Antibody Yield 
//g ml" 1
41
43
44
50
51
43
known to contain more nutrients than newborn calf serum. To test if there is any 
additional advantage of Biopro over foetal calf serum and peptone, the effect of 
which may also be due to amino acid release, a comparative experiment was set 
up. Table 6 shows the results of duplicate batch cultures prepared as described for 
the previous experiment. Foetal Calf Serum (FCS) has the largest effect on cell 
growth, and Biopro appears not to effect any extra advantage. Biopro was less 
effective at increasing maximum cell numbers and viability index than peptone.
A continuous culture was run at a dilution rate of 0.005 hr" 1 , as described in 
Materials and Methods. A steady state cell concentration of 0.43xl06 cells ml" 1 
was achieved for RPMI and 5% NBS and addition of Biopro increased this to 
0.53xlO6 cells ml- 1 .
In summary the use of Biopro increases both maximum cell concentrations 
and antibody productivity concomitantly, no particular effect on cell specific an- 
tibody production was noticed. The increases were smaller than those produced 
by peptone. Biopro appears to have no particular advantage over peptone. In all 
further experiments using TBC3 0.25% w/v of meat peptone was added to the 
medium.
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Table 6: Comparison of the growth of TBC3 in medium supplemented with either 
5% NBS, plus Biopro or peptone, or 5% FCS, with Biopro.
Serum
NBS
NBS 
NBS
FCS
FCS
Supplement
Biopro 
Peptone
Biopro
Max. Cell Density 
xlO6 cells ml'1
0.97
1.03 
1.19 
1.25
1.22
Viability Index 
x 106 cell x hours ml"1
34.8
39.0 
40.0
47.6
48.3
4.3 Lactate and Ammonium Toxicity
Lactate and ammonia are toxic by-products of metabolism which have been re- 
ported to limit batch cultures of hybridoma cells (Butler, 1987; Doyle and Butler, 
1990; Murdin et a/., 1989; Reuveny et a/., 1987). The toxicity of lactate is pre- 
sumed to be due to the increase in osmolarity caused by producing two lactate 
molecules for each glucose molecule consumed, as shown by controlled osmolarity 
chemostat studies (Omasa et a/., 1992). Ammonium toxicity is more complex 
but is thought to be due to intracellular acidifiction caused by active transport of 
into the cell, disassociation into NHs and H+ and diffusion of the non-polar 
out (McQueen and Bailey, 1990). Hybridoma cells vary in their sensitivity 
to both (Hassell et a/., 1987).
In order to test the sensitivity of TBC3 to lactate triplicate 50ml batch cul- 
tures were setup with 0,20,40 and 60 xlO~3 M/~ 1 of lactic acid and the pH was 
readjusted to 7.0 with NaOH before inoculation. Figure 15 shows the growth of 
the cells. Maximum cell density decreased with increasing lactate concentration 
in a linear manner, so that at a concentration of 57 xlO~3 M/~1 no cell growth 
would be expected. In batch cultures of TBC3 the final concentration is 25-30
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Figure 10).
A similar experiment was set-up to measure ammonium toxicity, with ammo- 
nium added as ammonium chloride to make concentrations of 0,1,2 and 3 mM. 
pH was readjusted with HC1. A linear decrease in cell concentration was seen. 
By least squares linear regression of maximum cell density, cell growth would 
be expected to fall to zero at 5 xlO"3^/"1 . Batch cultures of TBC3 produce 
approximately 1.5 xlO~3 M/~ 1 (see Figure 10).
The final concentration of lactate and ammonia in batch culture are less than 
30 xlO~3 M/~1 and 1.5 xlO~3M/~1respectively (figure 36). These concentrations 
were less than athose observed to affect initial growth rate in the previous batch 
cultures and although the batch cultures both showed some decrease in maximum 
cell density by this point they would have accumulated at least double the ac- 
cumulated amount of either metabolite. Thus the observed levels of lactate and 
ammonia in dialysis culture are in the range where they may be expected to affect 
the cells but they are both at the bottom end of this range.
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Figure 15: Effect of exogenous lactate addition on the growth of TBC3 in batch 
culture.
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Chapter 5
Large Scale Dialysis Culture
5.1 Results 
5.1.1 Supply Mode
In the work described in the previous chapter TBC3 was grown in a dialysis 
bottle device. This showed that cell densities were enhanced and the reaction 
time was extended. However culture conditions were not precisely controllable, 
and the resulting cell and nutrient concentrations were variable. To improve the 
precision of parameter control and agitation, a one litre working volume stirred 
tank bioreactor with pH and dissolved oxygen control was used.
The bioreactor had a top driven agitator suspended at 1/3 of the distance 
from the bottom of the reactor to the waterline. To prevent the membrane from 
touching the impeller and to increase the area of membrane within the reactor, 
an idea was borrowed from Hagerdorn and Kargi (1990). A length of copper wire 
sealed into silicone tubing was threaded inside the dialysis tubing. The copper 
wire acts as a shapeable former. The former allows the tubing to be supported in
75
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a helical shape away from the impeller and itself.
Four modes of nutrient supply to a dialysis device have been defined in the 
introduction (Figure 6). Since the principal advantages of the dialysis device stem 
from increasing cell densities and product concentrations and decreasing the use 
of high molecular weight medium components, the batch reactor configurations 
were chosen. Batch and continuous reservoir configurations were compared. The 
device described in the previous chapter was a batch reservoir and batch reactor 
device and this was used first.
The reactor was set-up in the same way as the dialysis bottle device (Fig- 
ure 12). From a five litre reservoir basal medium plus peptone (0.25% w/v) and 
Pluronic F.68 (0.05% w/v) was recirculated at 10 ml per minute through 370 
cm2 of dialysis tubing (1m length). The tubing was suspended in 900 ml of 
fresh medium (5% NBS, 0.25% peptone, 0.05% Pluronic), within a pH (7.0) and 
DOT (50%) controlled bioreactor agitated at 100 rpm. This reactor was inoc- 
ulated with 100 ml of cell suspension at 1.3xl06 cells ml" 1 . 4.1 litres of basal 
medium was placed in the reservoir so that the total volume of fresh medium in 
the reactor/reservoir system was 5.0 litres out of the 5.1 litre total volume.
Figure 17 shows the results of such a run. Exponential growth rapidly increased 
the cell concentration to 3.8xl06 cells ml" 1 , which is five times the value achieved 
in standard batch culture. The cell number then fell to 3.3xl06 cells ml" 1 within 
eight hours after which it was steady for 24 hours. This type of steady-state is not 
normally seen in batch culture and may be the result of a limitation of transfer 
through the membrane. This hypothesis is supported by the observation that the 
death phase (decline in cell densities and viability) coincided with glucose running 
out. The time taken by the reaction was 165 hours, about 1.5 times that seen
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Table 7: The viability index per basal medium ratio, for batch cultures and two 
modes of dialysis culture
]\
Reactor
Batch 
Batch 
Batch
'lode 
Reservoir
Batch 
Continuous
Viability index per litre 
xlO6 cell-hrsl- 1
42.3 
53.6 
76.0
in batch culture. The reaction time was not extended much because of the rapid 
growth to higher cell densities. The viability index was increased to 269xlO6 
cell-hrs ml" 1 , 6 times that seen in batch culture. The ratio of viability index to 
basal medium was slightly increased over a standard batch culture.
Figure 18 shows the results of a batch reaction with a continuous reservoir set 
up as shown in Figure 7. The conditions used were the same as in the previous 
example except that the total volume of the recirculation loop was 500 ml, and 
the contents of that loop were continuously replenished at 0.5 litres day"1 .
Cell concentration reached a maximum of 2.1 x 106 cells ml" 1 then settled to a 
steady-state value at 1.9xl06 cells ml" 1 . This value is similar to that seen in the 
dialysis bottle device and 2.5 times that seen in batch culture. Cell concentra- 
tions between 1.9-2.1xl06 cells ml" 1 were maintained for a period of 200 hours. 
Viability fell at the beginning of the steady-state to 40% and remained there. 
Glucose reached a steady state concentration at 0.2g I" 1 . The viability index was 
500 xlO6 cell-hrs ml" 1 , 12 times that of a batch culture. Expressed as viability 
index per litre (Table 7) the dialysis culture achieves nearly double the ratio of 
viability index to basal medium that the batch culture does and 1.4 times that of 
the batch/batch dialysis reactor.
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Figure 17: Growth of TBC3 in a controlled dialysis bioreactor with a batch cell 
space and batch reservoir. Cell concentration (O)> Viability (D).
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Two modes of feeding have been compared. The batch system with a large 
reservoir leads to higher peak cell concentrations and a longer exponential phase. 
Continuous feeding gives steady-states in cell concentration, viability and nutrient 
concentration. The reaction run can be extended significantly over batch/batch 
systems. The production of cell hours per unit of medium is higher. Steady-state 
conditions are amenable to simple modeling which will help in understanding the 
constraints on the system. In the next section some physical factors affecting 
nutrient transfer and cell concentrations are explored.
A 3 H Thymidine incorporation experiment showed that DNA synthesis was 
occurring during the steady states. The average value for one steady state (Fig- 
ure 29) was 689 ± 108 counts per minute (cpm), after correction for the blank 
(98.4 cpm); a control sample where the Thymidine was added immediately before 
quenching. This shows that cell division and, as the system is at steady-state, cell 
death is occurring.
To estimate the rate of cell division from the Thymidine incorporation rate 
it must be assumed that the relationship between the two is linear (Borth et a/., 
1992). In a culture in the early exponential stages of batch growth the rate of 
cell death is likely to be small. In such a population the rate of cell division 
can be estimated by comparing the viable cell count between successive samples 
(Equation 1).
Then a constant of proportionality (c) can be calculated (Equation 2).
cpm (2)
For sample E (Figure 29 a corrected cpm of 2064 was recorded. The growth rate 
as calculated by Equation 1 was 0.53 d" 1 . The calculated value of ^ for the steady
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state is 0.16 d" 1 ±0.025. This equates to an average cell lifespan of 4.3 days. The 
rate of turnover is significantly more rapid than may be expected. The fact that 
the steady state is a dynamic equilibrium has consequences for modeling specific 
protein production (Section 1.2.2) and therefore reactor design.
5.1.2 Investigating Design Factors
5.1.2.1 Effect of Membrane Area
The effect of membrane area on steady state cell number was studied by setting up 
fermenters with different membrane areas. The standard length of dialysis tubing 
used was one metre, giving a membrane area of 372 cm2 . For this experiment 0.75, 
0.5 and 0.25 metres of tubing were used in consecutive runs. DOT was maintained 
at 50% by intermittent sparging with 02, at maximum cell concentrations sparging 
occurred for no more than 10% of the time. pH was controlled at 7.0 by automatic 
C02 or Na OH additions. Fresh basal medium, plus peptone and Pluronic, was 
pumped at a constant rate from a 5 litre container to the perfusate reservoir.
Steady-state cell concentrations were obtained for a 0.5 v/v/d perfusion rate 
(see Figure 19) using each length of tubing. Cell concentrations increased linearly 
with tubing length (Figure 20) and was therefore apparently limited by transfer 
across the membrane under these conditions. The relationship between membrane 
area and steady-state cell number is not expected to be linear over the whole of 
its range. At zero membrane area the steady-state cell number should be zero, 
no nutrient transfer, however the regression line does not return to the origin. 
At large membrane areas cell concentration should be limited by factors in the 
culture fluid.
During these steady-states the cell viability was approximately 30%. The
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precise value becomes very difficult to assess in low viability cultures because of 
the large quantity of debris.
5.1.2.2 Effect of Perfusion Rate
The cell number in an intensified system is chiefly controlled by the rate of ex- 
change of low molecular weight nutrients. In a membrane-limited system this 
can be expected to be a complex function of medium perfusion rate. In order to 
study this a range of steady-states was achieved by perfusing medium at different 
rates (see Figure 21 and table 8). The fermenter was operated as described above, 
using medium with peptone and Pluronic. At 0.5 1 d" 1 , the steady-state cell con- 
centration was 2.0 xlO6 cells ml" 1 . For a continuous culture without membrane 
retention at the same dilution rate, using the same medium and supplements, the 
steady-state cell concentration was 1.2xl06 cells ml" 1 (Al Rubeai et a/., 1992) and 
cell retention therefore seems to be responsible for increasing the yield of cells on 
medium by more than 50%. This is a reflection of the energetic costs entailed in 
synthesising biomass. Cell concentration increased with perfusion rate, the degree 
of increase tailing off at higher perfusion rates.
5.1.3 Calculation of Membrane Transfer Coefficients
To gain a better insight into the movement of nutrients through the system and 
the physical factors affecting it, a mathematical description of the system was 
constructed. Hagerdorn and Kargi (1990) describe a series of equations for the 
transport of nutrients into the fermenter from their perfusate reservoir which was 
not replenished ie. a batch reactor/batch reservoir system and this was adapted 
to our batch reactor/continuous reservoir system. Their equations are based on
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Figure 21: Effect of perfusion rate on steady-state cell concentration. Cell con- 
centration (O)> glucose (y), lactate (D), monoclonal antibody (O).
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Figure 22: Plot of the reciprocal of perfusion rate against the reciprocal of the 
steady-state cell concentration.
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Table 8: Steady-state cell concentrations xlO5 ml at a range of Perfusion rates
Perfusion Rate
Id-i
0
0.5 
1.0 
1.5 
2.0 
2.5
Cell Concentration 
xlO6 cells ml' 1
0
1.9 
2.8 
3.4 
3.9 
4.2
rate constants for the transfer of nutrients from the perfusate reservoir to the 
reactor across the membrane, multiplied by the ratio of membrane area to volume 
of culture. Figure 23 shows a schematic diagram of the membrane. Molecules pass 
through the membrane purely by a process of diffusion and the rate at which they 
do so will depend on the structure of the membrane, for example its thickness, 
pore density, pore size and structure and any charge on it; and the molecular type 
diffusing through in terms of charge, size etc. These factors should be constant for 
a particular membrane type and molecular species. Either side of the membrane 
there will be a region of stagnant liquid, through which the molecules must pass via 
a process of diffusion. The depths of these regions will depend on the flow of liquid 
in the tube and the bulk phase. In our system and in Hagerdorn and Kargi's, the 
flow through the dialysis tube was kept constant. The external agitation rate was 
also constant. Although the overall transfer coefficient should be related to the 
film transfer coefficients Kc and Kr and the membrane transfer coefficient Km by 
jt = •£- + -£- + ^-, in our experiments the agitation and flow conditions on either 
side of the membrane are constant and hence j^ is assumed as an approximation 
to vary only with ^-.
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Figure 23: A schematic diagram of the dialysis membrane. Km is the membrane 
transfer coefficient. Kr and Kc are the transfer coefficients for the stagnant liquid 
films on the reactor and perfusate faces of the membrane respectively.
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Figure 24: A simplified schematic diagram of our dialysis fermenter system. F= 
flow rate, Vc = volume of reservoir, Vr = volume of reactor, 5/ = feed substrate 
concentration, Sc = circulation volume substrate concentration, Sr = reactor sub- 
strate concentration, x = viable cell concentration, Qs = Specific rate of substrate
use.
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Figure 24 shows the distinction between the recirculated constant volume into 
which fresh substrate is fed and from which a product stream is bled and the 
reaction volume separated from it by the semi-permeable membrane. Substrate 
diffuses through the membrane in order to be consumed rapidly and irreversibly 
by the biomass in the reaction volume Vr . On the recirculating side the flow 
rate around the loop can be assumed to be high enough to produce an effectively 
constant concentration, 5C , of substrate in the mixing vessel and loop. The vessel 
is sufficiently well mixed that the fresh feed substrate (concentration Sj) can be 
considered to be instantly diluted and, since the product stream is taken from 
this vessel, this is also the concentration of substrate in that stream.
The substrate passes through the membrane due to the concentration gradient 
between the recirculated volume (Sc ) and the reaction side (5V). The membrane 
is characterised by an area Am and a transfer coefficient Km .
In the reaction volume Vr the substrate is consumed by the biomass at a 
specific rate Qs . In the steady-state the biomass concentration is maintained at 
a fixed value x. This is not to imply that the net rate of cell growth-cell death is 
zero. Qs therefore represents consumption both for growth and for maintenance.
Hence at steady-state, with no accumulation of substrate on either the recir- 
culated side or the reaction side of the membrane, the consumption of substrate 
in the reaction side equals both the transfer rate through the membrane and the 
difference in substrate flux between the fresh feed and product streams, both at 
a flow rate F:
VrxQs = FSf - FSC = AmKm (Sc - Sr ) (3)
and so:
K = F(S> ~ S
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The transfer coefficient for any substrate can therefore be calculated using only 
metabolic parameters. Similar balances can of course be made for products, in- 
cluding possible toxic metabolites such as ammonia and lactate. Replacing the S 
terms by P terms and assuming such components are not found in the fresh feed 
stream, then one can readily show that the product transfer coefficients are given 
by:
FPj
- PT )
The central assumption of such an analysis is that Qs and Qp terms are both 
constant and independent of the Sr and Pr values. The same assumption has been 
used elsewhere (Wang et a/., 1989) to estimate cell numbers in heterogeneous reac- 
tors where direct measurements of cell numbers are difficult. (Miller et a/., 1989a, 
1989b) showed however that Qs for glucose and glutamine varies independently 
with concentration and with specific growth rate and pH for a hybridoma cell 
line in continuous culture. The series of experiments described here was carried 
out at constant pH and DOT and with significant glucose concentrations in the 
product stream at all states, the fresh feed medium being supplemented with 2 
gl" 1 glucose. The validity of the assumption is further supported by the fact that 
the observed nutrient and cell concentrations measured over the full range of flow 
rates used match very well (see Table 9) those calculated using a specific uptake 
rate calculated for the lowest flow rate.
A similar analysis by (Szperalski et a/., 1994) for non-steady-state conditions 
includes a term for fouling of the membrane. During our runs no such fouling 
was observed as evidenced by the Km staying the same, keeping the Sc simulated 
and actual concentrations the same (see Table 9). This difference may be due 
to the different membrane configurations used, Szperalski et al used hollow fibre
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membranes in bundles. The close spacing of the fibres may be responsible for 
trapping particles leading to the fouling. Some types of hollow fibre membrane 
are supported by an external spongy layer and these would be more susceptible to 
clogging. The smooth surface of the dialysis membrane used here should be less 
able to pick up material. At the end of a long dialysis run accretion is observed 
on the surfaces of the reactor, but none is seen on the membrane except on the 
upper side in the few places where the membrane touches one of the sampling 
ports or probes.
The Km values for glucose and ammonia are identical to those produced by 
Hagerdorn and Kargi (1990) (see Table 10) and the value for lactate is similar. 
The transfer coefficient values differ between chemicals by more than two fold. It 
is possible then that the system might become limited by a factor which is poorly 
transferred across the membrane which normally would not be limiting in batch 
culture.
Membrane transfer coefficients supply necessary information for dialysis re- 
actor design. A single steady-state experiment on a small scale, with sufficient 
analysis of metabolites, should permit calculation of transfer coefficients for all the 
major metabolites. With knowledge of metabolic parameters for a cell line, such 
as average nutrient uptake rates, lactate and ammonia production rates and tox- 
icities and antibody production rates, it will be possible to optimise the medium. 
Through a further simplified analysis it is possible to estimate the maximum 
cell number that a given reactor configuration can support. If it is assumed that 
the cell number in the reactor is limited by a substrate S which can pass freely 
through the membrane, then its concentration in the reaction volume Sr can be
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Table 9: Comparison between experimental and simulated values for steady-state 
cell and nutrient concentrations. Simulated values were based on Km values 
and Qs values calculated from the 0.5 1/d perfusion rate. £=cell concentration, 
5=substratate concentration, (s)=simulated values.
Dr 
Id' 1
0.5
1.0
1.5
1.5
2.0
X
cells
2.0
2.8
3.4
3.8
4.2
z(s) 
ml- 1 x 106
1.9
2.8
3.4
3.9
4.2
Sc
7.0
7.5
8
8.0
7.7
Se (*) 1 Sr
mMl-1
7.3
7.8
8
7.9
8.0
10
11.2
12.8
12.8
13.4
Sr (a)
9.8
11.6
13.0
13.1
13.8
Table 10: Comparison of membrane transfer coefficients: experimental and from 
Hagerdorn and Kargi (1990).Units are m hr"1 .
^•mg 
^ma
Km/
Exp
1.6xl(T3 
3.7xl(T3 
2.2xl(T3
H+K
1.5xl(T3 
3.7 xlO~3 
1.7xlO~3
Calculations of transfer coefficients 
21 x 1CT 6 x (16.6 - 9.7) _
0.037 x (9.7 - 7.2)
21 x 10~6 x 1.29 
0.037 x (1.52 - 1.29)
21 x 1Q~ 6 x 7.14 
0.037 x (8.93 - 7.14)
-
= 3.7 x 1(T3
- 2.2 x 1(T3
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assumed to be rather low, certainly much less than 5C , so that:
Sc = FSf (6) 
AmKm + F
and also:
PQ
VrxQs = AmKmA K y+F (7)
At very high fresh feed flow rates F ^> AmKm and the biomass that could be 
maintained approaches a theoretical maximum value xm which is given by:
This equation contains only fixed variables and the maximum cell number achiev- 
able in a given reactor configuration is then fixed solely by the fresh feed substrate 
concentration. It will be noted that the performance is independent of the recir- 
culating volume. In practice this need only be set by the practicality of achieving 
the conditions required for good mixing and high recirculation rates for a given 
membrane area.
Equation 7 can therefore be expressed in the saturation form:
x = WTF (9)
where K = AmKm
Equation 9 can be expressed in the double reciprocal form:
I (K l\ 1
-= (  x- +  10 
x \xm r J xm
A plot of ^ against j gives a straight line of slope K/xm with intercepts on the 
x and y axes at   ^  and   respectively. Applying this to the data in Table 8 aj\. x 77T, ^""^
least squares regression was used to calculate the equation of the line from which 
values for xm and K were calculated (figure 22).
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mX
K 1.05
These equations have permitted prediction of steady-state cell concentrations 
without knowing the identity of the limiting nutrient. Increasing the flow rate 
bring diminishing returns at values above that of K, so a maximum useful per- 
fusion rate will be reached based on economic factors. Using the K value from 
the regression to calculate the Km for the limiting nutrient a figure of 0.12 cm2 
hr" 1 was obtained, a smaller value than the others previously calculated. This 
suggests that the limiting nutrient /product is unlikely to be lactate or ammonia, 
which have larger transfer coefficients. Though it may be glucose, the more likely 
possibility is glutamine. The maximum achievable cell concentration for this sys- 
tem is, then, approximately 5.9xl06 cells ml" 1 , compared to the maximum we 
have achieved which is 4.0xl06 cells ml" 1 . To increase the cell concentration sub- 
stantially from the present value would require large increases in perfusion rate. 
Increasing membrane area or using a different membrane type with a higher poros- 
ity, or molecular weight cut-off will increase the rate of transfer of the limiting 
nutrient and so will also increase the steady-state cell concentrations.
5.1.4 Testing
5.1.4.1 Half Membrane Area
To test the general applicability of the model derived above it was decided to use 
the parameters gained from the previous experiment to predict the cell concentra- 
tions under a different set of conditions. Equation 7 predicts and Figure 19 shows 
a dependence of cell concentration on membrane area, so it was decided to vary 
the latter. The area was reduced by half to 0.0185 m2 and therefore the value of
CHAPTER 5. LARGE SCALE DIALYSIS CULTURE 95
Table 11: Cell concentrations predicted for a membrane area of 0.0185m2 , using 
parameters from previous experiment
Flow rate
Id' 1
0.5
1.0
1.5
2.0
Predicted Cell Concentration
xlO6 cells ml- 1
1.47
1.96
2.20
2.35
K will be halved to 0.52; xm is also halved (Equation 8) to 2.94. Using equation 9 
the steady state cell concentrations can be predicted for a range of fresh feed flow 
rates. Table 11 shows the result of this calculation.
Figure 25 shows the result of a dialysis fermentation performed under identical 
conditions to those used for Figure 21, except that the membrane area was halved 
to 0.0185 m2 . Steady-states were obtained for fresh feed rates of 0.5, 1.0, 1.5 and 
2 Id" 1 . Figure 26 shows a comparison of the results obtained with those predicted 
on both straight and double reciprocal plots. The double reciprocal plot shows a 
straight line relationship, suggesting that the saturation kinetic argument holds 
in this case. However the value of K is 10 times higher than that predicted and 
the value of xm is 4 times that predicted (see Table 12
The difference in the value of K must be due to variations in the value of Km . 
These may be caused by differences in the permeability of the membrane or due 
to variations in the thickness of the surrounding liquid films.
The term for xm contains Km (Equation 8). However Km changes by half the
&
amount that xm does. The other factor in xm is -£• and since Sf has not changed 
then Qs must have increased by a factor of 2.5.
The change in Sf/Qs suggests either a genetic or physiological change in the
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Figure 25: Dialysis culture of TBC3 using 0.0185m2 of membrane. Cell concen­ 
tration (O)-
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Figure 26: Simulated (line) and measured (Q) cell concentration for a range of 
feed rates.
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Table 12: Comparison of K and xm values for the perfusion rate experiments at 
full and half membrane areas
K
Tubin 
1.0m
1.05
5.88
g Length
A
Measured (min,max)
5.04 (2,10) 
11.7 (5.6,33)
5m 
Expected
0.5 
2.94
Difference
10 (4,20) 
4 (2,10)
cell line. This in turn may lead to a change in the identity of the limiting substrate. 
A different limiting substrate will have a different Km value leading in part to the 
change seen here.
5.1.4.2 Double Strength Medium
Equation 7 suggests that the variables that control the steady state cell con­ 
centration are area/volume ratio, flow rate and limiting substrate concentration. 
The gains in cell concentrations with increasing flow rate diminish at it increases. 
Area to volume ratio follows a similar kinetic. Limiting substrate concentration, 
however, has a predicted linear relation to steady state cell concentration and is 
simple to alter. Since the identity of the limiting component is not known all the 
medium components must be changed. Jo et al. (1990) have grown a hybridoma 
cell line in medium based on RPMI 1640 but containing 5 times the concentra­ 
tion of amino acids and vitamins and 2.5 times the concentration of glucose. By 
lowering the concentration of Na Cl the osmolarity of the medium was kept at 
its normal value of 270 mOskg"1 water. Final antibody concentrations increased, 
under batch cultivation, by up to 8 fold over standard RPMI 1640. The experi-
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merits were repeated in this laboratory using commercial vitamin and amino acid 
concentrates (Sigma). Stoichiometric increases in viability index were achieved 
with double strength and quintuple strength medium (results not published) and 
normal batch culture behavior was seen. It was, therefore, decided to use double 
strength medium in the dialysis device.
Figure 27 shows the progress of a dialysis fermentation in the standard mode 
in the Setric fermenter, using 1 metre of tubing and 0.5 Id" 1 of fresh feed medium. 
Two times RPMI 1640 was made by adding 50 ml of 100 x RPMI 1640 vitamins 
(Sigma) and 100ml of 50x RPMI 1640 (does not contain glutamine), 10 g Glucose 
and 0.5g of glutamine with the standard Peptone and Pluronic supplements, whilst 
making up the medium as described in Materials and Methods. The medium does 
not contain double the quantity of glucose or peptone.
The reactor was started in batch mode with single strength medium and after 
24 hours during which the cells doubled in concentration, the circulation tank 
was filled with medium and recirculation started. After a further 20 hours the cell 
density had again doubled. Perfusion was started at 0.5 Id" 1 , but after 8 hours the 
cell number had not increased further, viability had fallen and the viable cells had 
become small and irregular in outline. The perfusion rate was increased to 1 Id" 1 
but cell density did not increase further. With the standard medium composition 
at 1 Id" 1 , 3xl06 cells ml" 1 are to be expected, but this cell density is 40% of that 
value.
The most likely reason for these effects is toxicity. In batch culture this medium 
could be tolerated. The reason for this is not clear. It may be due to physiological 
adaption or differences in the physical conditions in the two systems. pH drop­ 
ping in the batch culture may slow down metabolism allowing adaption to occur.
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Figure 27: Dialysis culture of TBC3 using double strength medium. Cell concen­ 
tration (O)? % viability
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Alternatively the toxicity may lead to a weakening of the cells physically leading 
to damage in the stirred reactor.
5.1.5 Design and process improvements in dialysis culture
For a commercially useful device a method of arranging the dialysis membrane 
should be developed which allows it to be externally fabricated and then simply 
positioned within the reactor. It should be securely positioned so that it will 
not contact with the impeller and must be reasonably robust. It was decided 
that we should try the pleating solution as it was felt that this could be simply 
effected by placing the dialysis tubing over a rigid core. Medium is passed through 
the centre of the core and then flows upwards past the dialysis tubing, returning 
to the nutrient reservoir (see Figure 28). This design could easily be fabricated 
externally and then "plugged" into the fermenter.
For this run a further modification was also tested involving the implemen­ 
tation of a draw and fill operating regime for the cell-side bioreactor contents. 
Up to now this form of dialysis culture is essentially a batch process, however 
the production of the biomass inoculum for large fermenters is itself a costly pro­ 
cess. One potential way to improve the process efficiency is to attempt a periodic 
selective harvest of clarified medium from the cell-side of the bioreactor whilst 
retaining the cells. In this way the antibody, and also hopefully any proteases, 
can be removed. A simple way in which this could be achieved is by letting the 
cells settle and then drawing off the culture fluid above it.
Figure 29 shows the growth of TBC3 in a dialysis reactor using a 1m2 pleated 
membrane. As in previous experiments, pH and dissolved oxygen tension were 
controlled at 7.0 and 50% of air saturation respectively. The perfusate consisted
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of RPMI 1640 with 0.25% w/v of meat peptone and 0.12% Pluronic F68 and 
an additional 5.5 mmol litre of glucose was added. The cells were inoculated at 
O.TxlO6 cells ml" 1 and perfusion was started immediately. Steady-state cell con­ 
centration was achieved at a perfusion rate of 0.5 v/v/d giving 1.5x 106 cells ml" 1 . 
This compares with 2.0xl06 cells ml" 1 observed using 1 m2 of membrane in the 
coiled configuration (see Table 8). This suggests that the membrane was acting at 
the same efficiency as 0.75m2 of membrane in a coiled configuration. Observation 
of the membrane within the reactor shows that upon medium recirculation some 
areas between the pleats became tightly folded denying access to the culture fluid 
and therefore not all the membrane area was available for dialysis.
At 270 hours one litre of RPMI 1640 with 5% new born calf serum was added to 
the reaction volume, the cells were allowed to settle for a short while and then one 
litre of culture fluid was removed from the reactor. The process of removing the 
culture fluid disturbed the cells and following removal of the fluid the cell count 
had gone down from 1.6xl06 cells ml" 1 to 0.87xl06 cells ml" 1 . Perfusion was 
continued at 0.5 litres per day and the cell concentration returned to its normal 
value. The two antibody harvests, both of one litre, contained 420 /^g ml~ 1and 
730 //g ml"Respectively. To make this procedure more effective a method of 
withdrawing medium without withdrawing cells should be investigated.
5.2 Discussion: What controls cell density?
The value of the steady-state cell concentration achieved by the dialysis culture 
device depends on 2 sets of factors; physical factors affecting the rate of nutrient 
transfer to and from the system and physiological factors affecting the specific
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Figure 28: A method of placing dialysis tubing within a bioreactor. The tubing 
is threaded onto a stainless steel tube that reached the bottom of the reactor. 
One metre of tubing was bunched up on 0.15 metre's of tube. At either ends the 
tubing was sealed over a rubber bung which contained appropriate holes to allow 
medium to be recirculated. Medium passed down the inside of the stainless steel 
pipe, up through the dialysis tubing then back to the reservoir.
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Figure 29: TBC3 in dialysis culture using the method of membrane placement 
shown in Figure28. At the point shown by the arrow half the culture was removed 
and replaced with fresh medium
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requirement of the cells for nutrients and inhibition caused by the presence of 
toxic by-products of metabolism.
5.2.1 Physical Factors
The parameters affecting the transfer of nutrients have been simply modeled in 
section 5.1.3. The model presented there shows the importance of the values of 
the surface area to volume ratios, the transfer efficiency of the membrane, flow 
rate of the fresh feed and the feed substrate concentration.
5.2.1.1 Surface area to volume ratio
Experiment 21 showed that the dialysis system as it stands is limited by the ab­ 
solute rate of transfer of components across the membrane. One possible way of 
increasing the steady-state cell concentration is to increase the membrane area in 
the reactor. Schultz and Gerhardt (1969) suggest that a surface area of up to 10 
cm2 ml" 1 could be achieved with an external dialyser of 10% of the reactor volume. 
Our system achieves 0.4 cm2 ml" 1 . This value can be increased but at the expense 
of the homogeneity of the biomass and accretion of debris caused by stagnant re­ 
gions. Smaller tubing diameter will give a higher surface area to volume ratio. 
Boehringer Mannheim use and have patented the use of hollow fibre bundles fixed 
internally, which is the logical conclusion of using smaller tubing diameter. How­ 
ever they have observed and had to allow for in their model, significant clogging 
of the membrane (Szperalski et a/., 1994). This has not been apparent with our 
membrane configuration as the Km values calculated do not decrease during the 
course of the reaction run. The clogging observed in the hollow fibre system may 
be due to the membrane type, or it may have occurred because close placement
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is over 10 times the figure achieved in the reactor we operated. Reducing the 
radius of the tubing allows greater surface area per unit volume, at the expense of 
increasing the length of tubing to be arranged in the reactor. For example, from 
equation 11, the 0.6 litre holdup calculated above equals 2.1 metres of tubing. 
Methods of placing this within the reactor would become increasingly important 
as the length increases and this raises two issues; supporting the membrane rigidly 
away from its neighbours and the impeller and avoiding kinks in the tubing as it 
is coiled. Using the standard coiled configuration the copper former is successful 
within each turn of the coil, however inter-turn support of the coil would be 
beneficial and this could be achieved with a hook and frame arrangement. Dialysis 
tubing produced with a natural coil would solve the second issue. Alternatively, 
lengths of tubing could be suspended vertically connected by a distributor plate 
at the top and bottom (Figure 30). If the requirement for a standard stirred tank 
reactor is dropped, reactors with external loops which allow forced circulation 
past the membrane could be used, giving substantially higher membrane to liquid 
ratios
5.2.1.2 Transfer Coefficient
The amount of material transferred through a membrane depends on the difference 
in concentration across the membrane and the resistance to transport caused by 
the membrane. Two factors affect the size of the membrane transport coefficient:
• The membrane itself hinders the diffusion of the solute across it.
• Concentration gradients may exist in the liquid either side of the membrane
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of the fibres allowed accretion between them.
What is the maximum surface area to culture volume ratio achievable in this 
system? The dialysis tubing has a volume (V^), the radius (r) of which affects the 
working volume of the reactor. Surface area and volume are related as below:
(11) 
r
If a standard stirred reactor is used, then space must be left for the impeller and 
other projections into the culture volume. Tubing can then take up as large a 
fraction as is consistent with good mixing to minimise accretion and Nernst films 
(see section 5.2.1.2.2). This is not simple to assess as it will depend on the reactor 
geometry, impeller type, etc. Impeller radius is a fraction (w) of the radius of the 
reactor. Since the height of the liquid in the reactor depends also on the volume 
of the tubing the approach we take is to consider the volume taken by the dialysis 
tubing as an area and a fraction (g] of the remaining area after removal of the 
area taken by the impeller (w) which when multiplied by the culture volume gives 
the holdup.
_ __ Tubing Area
Total Area - Tubing Area
_ y~ Vr —— 2z —
Dividing by ngr2 this simplifies to:-
_ VT x (1 -
Given Vr = 1 litre, with an impeller of half the diameter of the reactor (w=0.5) 
and half the remaining area as tubing (g=0.5) the tubing volume Vt equals 0.6 1. 
Applying equation 11 the specific area produced by this is 4.0 cm2 ml" 1 . This
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Figure 30: Another way of placing dialysis tubing within a reactor, consisting of 
circular tubes top and bottom with the dialysis tubing connecting them. Medium 
enters a toral distributor plate (silver) and flows up through lengths of dialysis 
tubing (red) to another distributor plate and is recycled.
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5.2.1.2.1 Hindrance to transport in the membrane Semi-permeable mem­ 
branes do not consist of an array of even sized, straight sided, holes that stretch the 
width of the membrane, rather they consist of an irregular three-dimensional net 
of different sized holes. A molecule passing the membrane would therefore have 
to negotiate a maze of interconnected passages. The rate of passage of molecules 
through the membrane will depend on the average length of the passage of the 
solute through the membrane and this is affected by the depth of the membrane 
and the way the passages are connected. These terms are summed as the tortu­ 
osity (r). The percentage of the volume of the membrane that is accessible to the 
solute is known as the porosity (e). An ideal semi-permeable membrane would 
offer the same hindrance to transport to all solutes of molecular weight less than 
its cut-off. In practice larger solutes may not be able to enter smaller pores and 
thus they see a smaller porosity. This effect is known as the sieving factor (H ) and 
an empirical formula had been developed to account for it (Mason and Lonsdale, 
1990)
H = (l- m/M)2 (15)
where m is the radius of the molecule and M is the average radius of the passages. 
Similarly, larger molecules will experience a greater degree of drag due to edge 
effects (/) and an empirical expression for this factor is:
______1 - (m/M) 2 -5______ 
~ 1 - 0.3956(m/M) + 1.0616(m/M)2 ( ^
The size of the membrane portion of the transfer coefficient can therefore be 
estimated from those characteristics of the membrane which have the effect of 
modulating the diffusivity of the solute in free solution D0 .
Km w (-) HID0 (IT)
\T /
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Table 13: Estimation of the hindrance to solute movement caused by the mem­ 
brane for a number of different solutes and a 12,000 dalton cut off regenerated 
cellulose membrane. Based on the method of Mason and Lonsdale (1990)
Molecular weight (g j x )
\fM.Wt.
m/M
Diffusivity (cm 2 hr" 1 )
HI
Calculated membrane transport coefficient (cm hr 1 )
Measured membrane transport coefficient (cm hr — 1 )
Glucose
180
5.65
0.247
19.2
0.290
0.92
0.16
Lactate
90
4.48
0.196
25.0
0.390
1.61
0.22
Ammonia
18
2.62
0.122
47.2
0.591
4.58
0.37
Pore
12,000
22.89
Table 14: Normalised values for the diffusion of metabolites. Free: in dilute aque­ 
ous solution; Experimental: as measured using equation 21 and seen in table 10; 
Calculated: as shown in table 13
Solute
Glucose 
Lactate 
Ammonium
Diffusion coefficient 
Free Measured Calculated
1 1 
1.3 1.37 
2.45 2.3
1 
1.75 
5.00
Values of c (0.33) and r (2) for similar membranes can be found in the literature 
(Sakai et a/., 1987). Molecular radius can be estimated from the the square root 
of the molecular weight and diffusivities of solutes in water are available in the 
literature (Green and Malony, 1984). Table 13 shows these calculations for the 
metabolites measured during the dialysis runs.
The values calculated are approximately ten times higher than those measured. 
This suggests that the boundary layer diffusion resistance could be significant. If 
this is so then the variations in the membrane transport coefficients should reflect 
the free diffusivity of the molecule more than the membrane hindered diffusion. 
Table 14 shows the values for the diffusion coefficients normalised to the value for 
glucose, from which it can be seen that this is indeed the case.
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5.2.1.2.2 Hindrance to transport in liquid films Fluids flow in either a 
laminar or turbulent manner. Turbulent liquid flow will minimise the depth of 
the layers of stationary liquid either side of the membrane known as the Nernst 
films. Whether the liquid flow is laminar or turbulent can be predicted by the 
Reynolds Number of the system (Coulson et a/., 1990).
Because the pump speed is fixed, the circulation velocity of the liquid inside 
the membrane is constant. Treating the dialysis tube as a a cylinder the Reynolds 
Number can be estimated as :-
(18)
9
where r is the diameter of the tubing, v is the velocity of the liquid, p is the density 
of the fluid and 0 is the viscosity. Using the values for water as approximations 
the density equals 1 X 10~3 kg m3 and the viscosity is 1 x 10~3 Ns m" 1 (Coulson 
et a/., 1990). The dialysis tubing used was 0.012 m in diameter and the flow rate 
was 10 ml min" 1 and hence the Reynolds number can be calculated to be 18 i.e. 
it is in the laminar region. To obtain turbulent flow a considerable increase in 
the flow rates would be required and this would only be possible by putting a 
significant pressure difference across the membrane, which could in turn lead to 
significant convective transfer of liquid across the membrane (see section 5.2.1.3). 
Flow on the outside of the membrane is controlled by the impeller. The im­ 
peller speed used in this series of experiments was limited to 100 rpm. Impeller 
size was limited by the necessity of placing the membrane within the reactor. The 
impeller Reynolds number of a reactor with a Rushton turbine is given by the
following equation:
pD2N
where p + <f) are as above TV is the rotation rate of the agitator in hertz (0.167)
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and D is the impeller diameter in meters (0.04). This gives a Reynolds number of 
2667. This is just in the turbulent region for stirred tanks (Coulson et al., 1990). 
Nevertheless more vigorous mixing may be desirable to minimise the size of the 
Nernst films and minimise any accumulation of debris on the upper surfaces of 
the membrane.
Studies performed in this laboratory (Oh et a/., 1992), with TBC3 show that 
the cell is capable of growing whilst being subjected to greater rates of agitation. 
Greater Reynolds numbers may be achieved with a larger impeller but this takes 
up more space.
Referring to the term K in Equation 8, it has been shown above that the values 
of Am and Km may both be increased, under ideal circumstances by a factor of 
10. By assuming that overall an increase in K by a factor of 10 is possible and 
using this in Equation 8 cell concentration against perfusion rate was estimated 
(Figure 31). At 2.5 1 d" 1 the estimated cell concentration rose from 4xl06 cells 
ml- 1 to llxlO6 cells ml- 1 .
5.2.1.3 Pressure Differences
In theory concentration gradients of solutes, or pressure differences across the 
membrane, could cause significant transfer of volume via pressure differences. In 
practice this was not observed in the experiments conducted probably because 
the various effects canceled each other out. However, in some situations such 
as a pressure gradient caused by either poor gas exit from the reactor, or by 
pressure caused by pumping in the circulation loop, substantial transfer could 
occur (Schultz and Gerhardt, 1969).
The rate of dialysis through a semi-permeable membrane is defined by the
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Figure 31: Cell concentration verses perfusion rate as modeled by Equation 8. 
From experimental values (—), calculated assuming that K may be increased by 
a factor of 10 (...)
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following equation (Staverman, 1952).
Q = Kf (&P -RT^ <n&Si) (20)
where Q is the filtration rate through the membrane (cm3 hr" 1 ), Kj is an empir­ 
ically determined constant, AP the difference in pressure across the membrane 
and R is the gas constant, T is the temperature in degrees kelvin, A 6; is the 
concentration gradient of a solute, <j; is the reflection constant for that solute 
which accounts for the non-ideal semi-permeable behavior of membranes (1 for 
non-permeable solutes to 0 for freely permeable solutes).
If A5 is considered to be zero, then the equation simplifies to.
Q = K,P (21)
Kj has been estimated, for cellulose dialysis membranes, to be approximately 
6xlO~2 cnAtm"1 hr" 1 (Renkin, 1954). Given a pressure difference of 0.1 atm, 
Q— 2.4 cm3 hr" 1 cm~2 . This gives a total transfer rate for the dialysis reactor 
of 57.6 cm3 day" 1 , i.e. one whole volume of the reactor (1 litre) in 418 hours. 
Pressure differences therefore must be considered when designing and operating 
dialysis reactors. Osmotic pressure differences could be used to advantage to 
replace liquid volume in the reactor or to concentrate the contents of the reactor 
(Schultz and Gerhardt, 1969).
5.2.1.4 Fresh Feed Flow
Fresh feed flow rate is the operational variable that controls the value of the 
steady-state cell concentration. Increases in flow rate give diminishing returns 
in increased cell concentration because the perfusing medium tends to its feed 
concentration. Given that specific productivity is not a variable of flow rate or
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cell concentration then volumetric productivity is a linear function of flow rate. 
The value of the feed rate chosen will depend on the required rate of production.
5.2.1.5 Nutrient Concentration
Increasing the nutrient concentration, according to the model, gives linear in­ 
creases in cell concentration. The model however does not account for the toxic 
effects of metabolic by-products. In practice, attempts to increase the medium 
concentration led to the cells dying in dialysis culture, but not in batch culture. 
The optimum balance of nutrients in medium for a dialysis culture may well be 
different to that for batch culture.
5.2.2 Physiological Factors
Given set physical conditions, the cell concentration achieved depends on a range 
of physiological factors. In Figures 35 and 48 it can be seen that given similar 
physical conditions and similar medium conditions significantly different steady- 
state cell densities were achieved by TBC3 and CHO (see 8.1). These differences 
must be caused by differences in cellular physiology.
Section 5.1.1 showed that significant rates of cell turnover were occurring dur­ 
ing so-called steady-states. The rates of cell division and cell death are inde­ 
pendent of each other but are influenced in opposite directions by similar factors, 
principal amongst them being the metabolite/product concentrations (Figure 32). 
Energy status i.e. the balance between energy generation and consumption, is also 
influenced by the concentrations of both substrates and products. Energy status 
may affect the rate of both the growth and death, and could be the mechanism 
for the effect of substrate and product concentrations. In the following sections
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we discuss some of these factors
As discussed previously (Section 4.3) the levels of the principal toxic metabo­ 
lites, lactate and ammonium, seen in our dialysis system, are less than have been 
implicated in significant inhibition of cell growth. In addition to this the data 
from section 5.1.3 for the Km value of the limiting factor suggests a higher molec­ 
ular weight than that of either lactate or ammonia, although this does not rule 
out the possibility of some unknown inhibitor.
5.2.2.1 Cell Turnover
Cell turnover rate influences the quantity of energy used in biomass construction, 
and thus the achieved cell concentration in energy limited systems, the viability, 
the cell-specific productivity (Al-Rubeai and Emery, 1990) and the release of 
intracellular proteases (see section 7.2.1).
The observed turnover of cells during the steady-state consists of three rates 
(see Figure 33). Firstly the rate of cell growth (/^), secondly the rate of cell death 
(kd] and thirdly the rate of dead cell disintegration (kr }.
%vfJ/ ~~ "Ev^d ~~ ^d^r \ )
Since we can measure the rate of cell division using DNA synthesis measurements, 
the other rates can be calculated given the cell concentration and the viability. 
At steady-state cell concetration and viability // = kd. Measurements of DNA 
synthesis for TBC3 give estimates for the cell division rate, at steady-state and 
thus also the cell death rate as 0.11-0.19 d~l. With viability at 40% kr = 0.165 - 
0.285C/- 1 .
Measured viability is a dynamic equilibrium between cell death and dead cell 
disintegration. Many authors assume that no cell turnover is occurring during
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Cell Turnover
Growth Death
Energy Production Energy Use
Energy Status
Figure 32: The effect of energy substrate/toxic by-product concentration on cell 
density and cell energy status. .S^substrate concentration, P=product concen­ 
tration, 0,0 positive and negative influences respectively.
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Debris
Figure 33: The three rates that control the value of steady-state cell concen­ 
tration and viability as denned in Equation 22. Rates://=cell division, kd=ce\\ 
death, fcr =dead cell disintegration. Concentrations :xv=viable cell concentration, 
cell concentration.
extended steady-state operation of their bioreactors (Ackermann et al., 1994; 
Robinson et a/., 1994). Table 15 shows rates of cell turnover during apparent 
steady-states for CHO, BHK and several hybridoma cell lines and a variety of cul­ 
ture systems. Cell turnover rates are in the range of 0.05-0.4 d" 1 . It seems likely 
that cell turnover is occurring during steady states in most perfusion systems.
Most of the references calculated turnover rate by assessing the rate of release 
of the intracellular enzyme lactate dehydrogenase (De Tremblay et a/., 1992). An­ 
other assessed the rate of DNA synthesis by blocking cell division with colchicine 
and measuring the accumulation of cells in the G2 stage of the cell cycle using 
flow cytometery (Borth et al, 1992). The final method used a measurement of 
the dead cell disintegration rate in a balance (as Equation 22) with the viable and 
dead cell concentration (Jan et a/., 1991).
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When the limiting substrate concentration falls to that of the order of the Km 
value, not the same as the membrane transfer coefficient, for the limiting enzyme 
in the pathway the growth rate will decrease significantly. At the same time as 
metabolic stress is put on the cells the death rate will increase until it balances 
the rate of cell growth and steady-state is achieved. The cell concentration is 
ultimately determined by the efficiency of use of medium (Y*.). The rate of cell 
turnover is determined by the rate of cell death.
Cell death may occur by either of two mechanisms (Scwartz and Osborne, 
1993). Necrosis is a passive process in which osmotic balance is disturbed due 
to plasma membrane damage which allows passive entry of ions most notably 
Ca2+ , this leads to the cell swelling. The Ca2+ concentration increases inhibiting 
many enzymatic pathways including ATP production and stimulating other such 
as proteolysis.
Apoptosis is an active process, it requires protein synthesis in order to proceed 
and is a significant source of cell death in bioreactors for some cell types, espe­ 
cially lymphoid cell lines (Singh et a/., 1994b). The surface membrane boils and 
"blebs" then pinches off to produce "apoptotic bodies". Chromatin condenses 
along inner surface of the nuclear membrane. DNA is digested by an endogenous 
nuclease which cleaves between nucleosomes leading to a distinctive banding effect 
after DNA electrophoresis with a repeat of 180 basepairs, the intra-nucleosomal 
repeat distance. Apoptosis is triggered by many things including growth factor 
concentration, irradiation, heat-shock, a variety of xenobiotics, and nutrient lim­ 
itation. Cells will die of apoptosis under these conditions unless the damage is 
severe enough to prevent protein synthesis in which case the cells die of necro­ 
sis. Necrosis will occur if the cell is subjected to mechanical damage or severe
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metabolic stress.
The bcl-2 proto-oncogene can inhibit apoptosis in a variety of cell types. BCL-2 
has been expressed in Burkitt's lymphoma cells (Gregory et a/., 1990). Compar­ 
ison of batch cultures of transfected and non-transfected examples of this cell 
line have shown that BCL-2 product increased the maximum cell density and vi­ 
ability index of stationary cultures (Singh et a/., 1994a). In another experiment 
cells were resuspended in glutamine-free medium. The apparent death rate of 
the transfected cells was considerably decreased in comparison to non-transfected 
cells. If these increases also occur in dialysis culture steady-state cell density could 
be improved by transfecting BCL-2 into hybridoma cells. Unless there is a change 
in efficiency of medium use this will not lead to increased steady-state cell densi­ 
ties. However, if the rate of cell turnover decreases the energy used to synthesise 
biomass will be saved. This will lead to an increased cell concentration.
The immediate death of TBC3 in double strength medium under dialysis but 
not batch conditions may be caused by triggering of apoptosis. One common 
factor amongst many of the triggers for apoptosis is that they increase the level 
of oxidative stress in cells (Buttke and Sandstrom, 1994). Serum contains a va­ 
riety of low and high molecular weight anti-oxidants. The low molecular weight 
anti-oxidants would be removed by dialysis. The double strength medium may 
provide a variety of metabolic stresses on the cell such as an increased ammonia 
concentration. This hypothesis is supported by the observation that the stressed 
cells had shrunk.
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Table 15: Cell turnover rate in immobilised cell systems. Culture systems^ Al- 
ginate entrapment (AE), microcarrier (MC), macroporous microcarrier (MMC), 
fibre pad (FP) cross-flow filtration (XFF) Hollow fibre, cells in extracappiliary 
space (HF) and dialysis (DLS). The turnover rates were calculated by measuring 
DNA synthesis rate, cell death rate by release of intracellular lactate dehydroge- 
nase (LDH), or calculated from measurements of dead cell destruction rate and 
total and viable cell concentrations.
Turnover Rate
(d- 1 )
0.05-0.125
0.10
0.10
0.30-0.40
0.17
0.30-0.33
0.24
0.30
0.12
0.15
Cell Line
CHO
BHK
Hyb
Hyb
Hyb
Hyb
Hyb
Hyb
CHO
Hyb
Culture System
MC
MMC
MC
FP
HF
AE + XFF
XFF
DLS
DLS
DLS
Method
DNA synthesis
LDH
LDH
LDH
Model
Model
LDH
Model
DNA synthesis
DNA synthesis
Reference
(Borth et a/., 1992)
(Kratje et al, 1994)
(De Tremblay et al., 1992)
(Yamaji and Fukuda, 1992)
(De la Broise et a/., 1992)
(De la Broise et a/., 1992)
(Pinton et al., 1991)
(Hagerdorn and Kargi, 1990
Own
Own
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5.2.2.2 Energy Production and Maintenance Energy
Cells have two basic uses for energy; for production of new biomass; and for 
a variety of functions needed to keep the cell viable, such as protein turnover, 
maintenance of ionic gradients etc., collectively known as maintenance. About 
60% of the ATP demand in a hybridoma cell line growing at 0.66 hr" 1 was used 
for maintenance according to Miller et al. (1988). The proportion of energy 
used for maintenance could be expected to rise as the cell division rate decreases. 
The specific demand for maintenance energy and the actual growth rate during 
apparent steady-states, determine the cell concentration achieved in those steady- 
states.
Adenosine tri-phosphate is the universal currency with which energy is ex­ 
changed within the cell (Alberts et a/., 1986). The rate at which it is produced can 
be simply estimated from oxygen uptake and lactate production data (Glacken, 
1988). This can vary according to the conditions experienced including growth 
rate (Hiller et a/., 1993) and nutrient supply. In Homo sapiens the rate of ATP 
production has a range from 0.4-9.0 g ATP/Kg body weight/hour (Erecinska and 
Wilson, 1981).
ATP production in hybridoma cells is apparently rather inefficient (Glacken, 
1988; Mancuso et a/., 1994). Most of the glucose is only partly oxidised to lactate 
instead of the much more efficient oxidation to C02 and H^O. Glutamine is also 
partly oxidised with production of alanine and aspartate. It has been suggested 
that the high glucose and glutamine fluxes are necessary to achieve sensitive con­ 
trol of nucleic acid and ribose phosphate synthesis (Szondy and Newsholme, 1990). 
Increases in efficiency of ATP production are therefore theoretically possible. In­ 
deed the natural dynamic range of ATP use in man is 20 fold (Erecinska and
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Wilson, 1981).
Maintenance energy may also be variable. Ammonia's toxic effects may be 
due to an increase in the need for ATP consuming, ion pumping, work which 
increases the level of the maintenance energy demand (Martinelle and Haggstrom, 
1993; Newland et a/., 1994). Lactate toxicity is probably due to increasing the 
osmolarity of the medium (Omasa et a/., 1992), thus increasing the osmotic work 
required to maintain intracellular ion concentration and thus also the maintenance 
energy demand.
In summary both the requirements for energy use by cells and their ability to 
produce it are variable depending on the cell type and the conditions experienced. 
The balance of these values will effect steady-state cell concentrations.
Chapter 6
Serum addition in dialysis mode
6.1 Introduction
Serum contains a variety of high and low molecular weight components which are 
often important for cell growth (Anderson and Lunden, 1976). Human plasma 
contains 70-80 gl" 1 of protein, including more than 150 enzymes. These proteins 
perform many functions, principle amongst them being transport of a variety of 
substances to and from the cells. Serum Albumin transports fatty acids, steroids 
and metal ions, Lipoproteins transport lipids and cholesterol, Transferrin trans­ 
ports iron. Other functions include; Protease inhibition, provision of growth fac­ 
tors, hormones, attachment factors, and immunoglobulins, and the actions of a 
variety of tissue derived enzymes (Fisheman and Doellgast, 1975).
Low molecular weight components present in serum include all the amino acids, 
vitamins and ions present in basal media such as RPMI 1640. Additionally it 
contains trace elements, lipids, cholesterol, steroid hormones and components that 
influence the redox potential of the medium.
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Many groups have been able to grow hybridomas in serum-free medium formu­ 
lations (Al-Rubeai and Emery, 1989; Jager, 1991; Nielsen and Bertheussen, 1991; 
Wyatt, 1994). These formulations come in two types, those in which protein func­ 
tions are replaced by a number of individual proteins either purified from tissue 
sources or produced by recombinant organisms in culture; and those other types of 
formulation, essentially protein free media, in which these functions are replaced 
by low molecular weight components. These media avoid the inherent variability 
of serum and, since they have a lower protein content, aid downstream processing, 
as well as presenting a smaller chance of introducing adventitious agents.
These media show that the functions of both high and low molecular weight 
components of serum are either not essential, or are replaceable in vitro. Why 
then use dialysis to retain high molecular weight medium components if they are 
not necessary?
Serum-free media have many disadvantages, which include: lower maximum 
cell densities and growth rates; loss of the protection from mechanical and oxida- 
tive stresses normally provided by serum; likewise less protection from proteolysis. 
However the serum-free formulations are more specific to individual cell lines than 
serum-containing formulations, and thus must often be reformulated for each new 
cell line. The protein-containing formulas are invariably more expensive than 
serum-containing formulations.
The basal medium that we used contains peptone which is a source of peptides 
and probably also lipids and trace elements. It also contains Pluronic F68 which 
has been included in many serum-free media formulations to protect against me­ 
chanical damage to the cell. Dialysis will remove the low molecular weight part of 
the serum. Previous experiments have shown that the cells are capable of grow-
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ing without them, in this medium for periods of hundreds of hours, so the basal 
medium is therefore competent for cell growth. But do low molecular weight 
serum components stimulate cell growth and increase steady state cell densities?
Dialysis will remove the molecular weight components below 12,000 Daltons, 
thus retaining the majority of the proteins,those with approximately 50 or more 
amino acid residues, within the reactor. These proteins will be within the reactor 
for extended periods of time and may be used up by the cell, or be degraded 
chemically or by proteases. Previous experiments do not show any fall off in steady 
state cell densities over time and this suggests that this effect is not significant 
over the time period studied. However higher concentrations of high molecular 
weight serum components may increase steady state cell densities.
In the experiments described in this section we investigate the role of both 
fractions of serum in the extended stationary states encountered in membrane 
bioreactor devices.
6.2 Results and Discussion
Duplicate batch cultures of 50 ml in stirred duran bottles were set up with a 
10% inoculum of TBC3. A 10 ml aliquot of serum was placed in dialysis tubing 
and dialysed against 1 litre phosphate buffered saline overnight at 4°C. A control 
aliquot was also kept at 4°C, but not dialysed. Glucose was measured at 0.71 g/1 in 
the dialysed serum and was not detectable (less than 0.05 g/1) in the non-dialysed 
serum. Batch cultures were set up with RPMI plus peptone and Pluronic, with 
whole serum or with dialysed serum.
Cell growth in dialysed serum was higher than in non-dialysed serum (Fig-
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ure 34). The viability index increased from 35.6xl06 cell hours to 41.5xl06 , and 
maximum cell density increased from 0.67 to 0.87 xlO6 cells ml"1 . Low molecular 
weight components of the serum are, it seems, not required at the concentrations 
high molecular weight components are, if at all. Multi-generational studies and 
more thorough dialysis would be needed to confirm a total lack of requirement.
Figure 35 shows that cells have been maintained in dialysis mode for 280 hours 
without addition of serum. pH and dissolved oxygen tension were maintained at 
7.0 and 50% air saturation respectively. The medium used was RPMI with 0.25% 
w/v meat peptone and 0.12% Pluronic F68. The reactor was inoculated with 
0.4 x 106 cells ml" 1 , and perfusion was started immediately at 0.5 litres per day. A 
steady state cell concentration was achieved at 1.5xl06 cells ml"1 . Cell viability 
dropped to below 50% where it stayed for the remainder of the run. At 170 
hours the perfusion rate was increased to 1.0 litres per day, and the viable cell 
concentration increased to 2.Ox 106 cells ml" 1 . Subsequent periodic additions of 25 
ml aliquots of NBS led to temporary increases in steady state cell concentration of 
30-50%. After approximately 2 days the viable cell concentration then returned to 
the original level. These increases would therefore appear to be due to factors that 
were either of low molecular weight and so rapidly diluted, or were short lived, or 
were rapidly sequestered. The fermenter glucose concentration was however zero 
during this period (figure 36).
In order to examine the possibility that the reaction shown in figure 35 was 
glucose limited, another dialysis fermentation was then set up (figure 37). The 
same medium was used as in the previous experiment, but with an additional 
5.5 mM per litre of glucose, bringing the total for the perfusate to 16.6 mM per 
litre perfusate. A steady state cell concentration at a perfusion rate of 1.0 Id" 1 of
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Figure 34: Comparison of the batch growth of TBC3 in dialysed and non-dialysed 
serum. Dialysed (D), Nondialysed (A), No serum (Q)
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Figure 35: TBC3 grown in dialysis culture with periodic additions of serum. (Q) 
cell concentration, (O) Antibody Concentration, (y) glucose concentration, (j) 
serum additions.
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Figure 36: Metabolite concentrations for the previous fermentation. (A)Reactor 
metabolite concentrations, (O) perfusate metabolite concentrations).
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3.1 x 106 cells ml" 1 was recorded, compared with 2.0 x 106 cells ml" 1 in the previous 
run (figure 35). The residual glucose concentration was now 3xlO~3M litre" 1 . At 
192 hours a 10% v/v solution of NBS in RPMI 1640 was added continuously at 
such a rate that 1% v/v of serum was added to the reaction volume daily. Volume 
was maintained at one litre by removing the same volume daily when samples 
were taken. Under these conditions cell concentrations appeared to decrease from 
their previous values. The effect then of adding additional serum appears to be 
less than the effect of removing cells. Serum additions into the reactor appear to 
have, if anything, a negative effect on steady state cell concentrations. The batch 
experiment showed the presence of inhibitory low molecular weight component(s). 
The continuous addition of serum showed that they were at least not stimulatory. 
It appears that the initial shot of serum is sufficient for periods of at least 450 
hours.
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Figure 37: TBC3 grown in dialysis culture with continuous serum addition. (Q) 
cell concentration (y) glucose concentration.
Chapter 7
Antibody Production
7.1 Product Accumulation
In dialysis culture antibody is retained within the system and, because the an­ 
tibody molecule is relatively stable, it is accumulated to high concentrations. In 
Figure 35 1440 fig ml~1of antibody seems to be the final concentration, while in 
Figure 21 the final antibody concentration is 1200 fig ml"1 . These values compare 
with those found in ascitic culture (1-10 mg ml"1 ) (Pannel and Milstein, 1992), 
and are 20-30 times that seen in simple batch culture. The antibody is produced 
throughout the culture. However Figure 38 shows a different pattern of antibody 
production. Antibody concentration peaks at about 600 fig ml~ 1and thereafter 
drops on two separate occasions. These drops in concentration may be due to 
release of proteases by the dead cells: van Erp et al. (1991a, 1991b), using hol­ 
low fibre bioreactors, noticed proteolytic activity leading to antibody degradation, 
and identified a cathepsin D type protease. This protease is normally found intra- 
cellularly, but may be released by dying cells. As our dialysis cultures at steady
133
CHAPTER 7. ANTIBODY PRODUCTION 134
state had viabilities in the region of 30-50%, it is reasonable to expect that there 
will be considerable protease activity present. Serum contains protease inhibitors 
so, in for example Figure 35, the lack of obvious protease activity may be due to 
the periodic additions of serum.
Specific cell productivity overall1 in Figure 35 is 4.10 mg 106cells" 1 hour" 1 
compared to 2.40mg 106cells~1 hour" 1 for a typical batch culture (table 4). Com­ 
paring the data with other data for this cell line in a variety of different culture 
devices and conditions (Al Rubeai et al., 1992) Figure 39 shows that the value 
is similar to that seen in a spin-filter device operated at high cell density and 
higher than seen in batch, continuous and the spin-filter system operated at low 
cell density. The reasons Al Rubeai et al (1992) ascribe to this high productivity 
in spin filter systems would equally apply to this system:-
• Prolongation of the more productive GI and S phases of growth.
• Release of antibody from retained dead cells.
It has been shown that this cell line stores part of the antibody it synthesises 
(Al-Rubeai and Emery, 1990) so the low viability seen in this culture will allow a 
lot of this extra antibody to be released. Cell turnover will allow this release from 
dead cells to continue throughout the duration of the reaction.
No large variations in the specific production rate were ascribable to changes in 
perfusion rate or serum addition. Smaller variations may well be missed, however, 
because of the inherent difficulties in measuring this derived variable.
• The ELISA assay is precise only to about 10% coefficient of variation (on a 
good day!) and the cell count only to 5%.
Calculated by dividing final antibody concentration by the total number of viable cell hours
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Figure 38: Dialysis fermentation with no addition of serum. (Q) Cell concentra­ 
tion, (O) antibody concentration.
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• Protease action will vary according to the quantity of protease inhibitors 
and the rate of protease release from dying cells.
• Release of antibody by dead cells will vary with the death rate of cells.
7.2 Cell size
Specific productivity has been measured on a per cell basis. However it has been 
suggested that a more reasonable basis for calculation is per weight of biomass 
(Spier, 1989). This is supported by evidence that the production of antibody 
is controlled at the level of translation (Bibila and Flickinger, 1991; Leno et a/., 
1991). Measurements of this parameter were not done, because direct measure­ 
ment of cell dry weight is difficult at this scale, due to the large quantity of biomass 
needed. Using forward scatter measurements in flow cytometry it is simple to mea­ 
sure relative cell size (Al-Rubeai and Emery, 1993). In Figure 40 forward scatter 
measurements are recorded for a dialysis culture (figure 41). It can be seen that 
the median cell size increases from that in the earlier samples. The cells during 
steady state are bigger and therefore the increases in specific productivity seen in 
dialysis culture over batch culture are partly due to an increase in the quantity of 
biomass.
7.2.1 Product Quality
Protein products in cell culture environments are exposed to a variety of chem­ 
ical and enzymatic agents that can alter them. Animal cells contain lysosomes, 
membrane bound sacs that contain enzymes for the destruction of amino acid, nu­ 
cleic acid and carbohydrate polymers. They have earned the nickname of "Suicide
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Figure 39: Comparison of the specific productivities of TBC3 in a number of 
different cell culture systems. Abbreviation: exp=exponential, Thy=Thymidine, 
LCDP= low cell density perfusion, HCDP= high cell density perfusion. Perfusion 
experiments used spin filter devices for cell retention.
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Figure 40: Forward Scatter flow-cytometry measurements for TB/C3 in dialysis 
culture (see figure 41).
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Id"1 . Cell concentration (Q), viability (D), Cell size
CHAPTER?. ANTIBODY PRODUCTION 140
Sacs". In the healthy cell these enzymes are used for orderly destruction of cellular 
components (Stryer, 1981). Their contents may be released from dead cells into 
the culture. Several groups have reported the presence of proteases in hybridoma 
cell supernatents (van Erp et al, 1991a; Karl et al, 1993; Kratje et al, 1994; Mo- 
han et al, 1993), and these have been implicated in the degradation of antibody. 
Similar reports have been made for insect cell supernatents (Jager et al, 1992), 
and CHO supernatents (Kratje et al, 1994). The situation with carbohydrate 
residues is more complex as the addition of carbohydrate residues to proteins de­ 
pends on the physiological condition of the cell and the nutrient environment that 
it is in for both Hybridoma (Patel et al, 1992), CHO (Hayter et al, 1992a) and 
insect cells (Fordham et al, 1992). Several groups reporting on antibody quality 
in extended culture systems do not notice any significant degradation (Ackermann 
et al, 1994; Robinson et al, 1994)
Dialysis culture, as it has been presented here, apparently optimises conditions 
which promote degradation, it. the product spends long periods of time in low 
viability culture. However, because of the retention of high molecular weight 
components, it becomes more economic to add protein protease inhibitors. A 
large fraction of the protein component of serum is protease inhibitor and it is 
indeed one of the concerns over the use of serum-free media that product is more 
liable to degradation as no inhibitors are present and the product forms a larger 
fraction of the total protein (no competition effect). Evidence of the protective 
effect of serum is contradictory, van Erp et al (199la) ascribe the protective 
effect of Foetal Calf Serum on antibody integrity mostly to competition effects, 
Pepstatin A was also found to protect the antibody. Jager et al (1992) added 
Antipain, a serine protease inhibitor, to insect cell supernatents and observed
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inhibition of proteolysis. Kratje et al. (1994) found that Aprotonin and Antipain 
were effective at inhibiting culture supernatant protease activity. There is evidence 
that different hybridoma cell lines release different proteases. For example Phenyl 
Methyl Sulphonyl Fluoride (PMSF) both inhibits (Kratje et al, 1994) and does 
not inhibit (van Erp et a/., 199la) protease activity in different cell lines.
Proteins are not homogeneous in their structure in cell culture supernatents. 
The question then is as to what degree of variation from the complete product 
is acceptable? This obviously depends on what it is to be used for. The most 
stringent requirements for use are likely to be those applied if the product is 
intended to be an in vivo therapeutic. The United States of America's Federal 
Drug Administration (FDA) guidelines for manufacturing protein drugs operate 
through the concept of licensing a product together with the facility used to 
produce it. This means that in the later stages of registration the precise details 
of the process become fixed and the product is defined by this. The precise state 
of the product that is acceptable is defined for every individual process, as it is 
for registration.
To obtain Figure 42: 20//g of supernatant from the experiment referred to in 
Figure 25 was added to each track of a non-reduced SDS polyacrylamide gel. The 
gel was run and then blotted. Four tracks were stained for protein with Coom- 
massie brilliant blue, the rest were conjugated with sheep anti mouse IgG poly- 
clonal antisera conjugated to peroxidase and developed with a di-amino-benzidine.
The presence of multiple banding in Figure 42 shows that some of the anti­ 
body protein is present as part molecules. Many of the bands are present as pairs. 
These pairs may be due to some of the molecules being un-glycosylated. Carbo­ 
hydrate residues form 2% of the mass of a complete molecule. The intensity of
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the bands increases with time as the antibody concentration increases. However 
there is no apparent change in the relative intensity of the bands. Since the early 
samples come from a culture at a high viability and thus, presumably a low con­ 
centration of, normally intracellular, protease, this suggests that any proteolytic 
processing that may be occurring is not critically dependant on released intracel­ 
lular protease. Another potential source of incomplete antibody is the release of 
partially completed antibody from inside the cell. The above argument applies 
also to this source. Additionally, incompletely assembled antibody should show 
banding molecular weights which are multiples of that of the individual chains 
(25 kD and 50 kD). Thus banding at 25 kD, 50kD and 75 kD would be expected. 
On the gel no bands can be seen below 60 kD. This was also observed by Mohan 
et al. (1993). Finally the rate of release of intracellular antibody is rather low 
(see section 5.2.2.1).
There is evidence then for the presence of incomplete antibody product. How­ 
ever there is little evidence that this is related to cell viability. Another source of 
this proteolytic effect may be secretion of proteases. Lind et al. (1991) showed 
that levels of proteolytic activity followed the viable cell concentration and sug­ 
gest that this is due to secretion of proteases. The multiplicity of different findings 
suggest that protease and proteolytic patterns are probably clone specific in hy- 
bridomas.
7.2.2 Economic Considerations
The cost of medium for hybridoma growth can vary tremendously depending on 
the costs of the supplements. Basal media, such as RPMI and DMEM, are rela­ 
tively cheap. One litre of basal medium bought as a powder costs approximately
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Figure 42: A western blot of samples from a dialysis culture (Figure 25). Each 
lanes consists of 20/ul of culture supernatent was run on a 8-20% non-reduced SDS 
poly-aerylamide gel, then electro-blotted probed with polyclonal anti-mouse IgG 
peroxidase conjugate and developed with di-amino-benzidine. The numbers above 
the lanes denote the time in days when the sample was taken.
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£1.05 (based on 1994 Gibco list prices) and considerable savings can be made by 
bulk purchase. A 5% supplement of New Born Bovine Serum costs £1.26, but 
many groups use 10% Foetal Bovine Serum and this costs £12 (1994). Serum-free 
medium supplements, such as Bovine Serum Albumin and Transferrin are costly. 
Antibiotics are also an expensive part of animal cell culture medium, but their 
use can be avoided by good aseptic technique. Dialysis culture's ability to avoid 
almost totally the use of serum, reduces the medium costs of production consid­ 
erably (see Table 16). The yield of antibody on basal medium is double that of 
batch culture and the yield of monoclonal antibody on serum is 19 times that of 
a batch culture. The medium cost per gram of MAb is therefore decreased from 
£48.80 to £0.93. Furthermore that antibody represents 25% of the total of five 
grams of protein. By contrast, the culture protein mass' in batch mode was 1.1 
gram, but the antibody formed just 2% of this total protein (Table 16).
7.3 Discussion: Specific Productivity
Specific productivity is a rate function and thus it doesn't have an instantaneous 
value. It is generally measured by comparing the antibody concentration in two 
separate samples. Comparing samples from the beginning and end of the dialysis 
run gives an overall rate, comparing adjacent samples gives a local rate. Figure 39 
shows a comparison of the overall rate of specific productivity in the dialysis 
reactor from a number of runs to similar data for some other reactor configurations 
with the same cell line. The rate of specific productivity in the dialysis can 
be seen to be higher than that in batch cultures and similar to that seen in 
spin-filter perfusion culture. However local variations in specific productivity are
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Table 16: Comparison of product yields and medium costs for a typical batch and 
dialysis culture. Estimates for the dialysis culture were taken from the last point 
prior to any serum additions.
Figure Number
Total Medium Used (litres)
Total Serum Used (litres)
Duration (hours)
Maximum Cell Cone. (xlO6 cells ml" 1 )
Viability Index (xlO6 cells ml^hr"1
Protein Concentration (grams litre" 1 )
Ab concentration (grams litre" 1 )
Yield Ab/Basal Medium (grams litre"1 )
Yield Ab/Serum (grams litre" 1 )
Ab/Total Protein
£/ gram Ab
Batch
9
1.0
0.05
96
0.85
45.0
1.1
0.045
0.045
0.090
2%
48.8
Dialysis
35
16.4
0.125
478
3.3
835.3
5.0
1.470
0.094
1.700
25%
9.30
Yield Calculations —
Yield Ab/BasalMedium =
Yield Ab/Serum =
Final antibody concentration (gl 
Total basal medium used(/)
Total Antibody harvested(p)
Total serum used(/)
Total Antibody harvested(g) \ 
Total Protein harvested(g) j
o_ 20.8 x Litres of serum used+i.isx Litres of medium used 
~~ Grams antibody harvested
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seen in several of the dialysis runs, including an overall reduction in antibody 
concentration seen in Figure 38. The notorious inaccuracy of the ELISA will 
account for some of the variations seen.
Hybridoma cells are genetically unstable. As fusions of two cells, they retain 
more than the standard diploid complement of chromosomes and are susceptible 
to chromosome loss. The antibody gene family has been shown in myeloma cells 
to be particularly susceptible to mutation (Morrison and Scharff, 1981). This 
may be because recombination is the basis of antibody diversity. Also one of the 
two immunoglobulin alleles is excluded from expression, regardless of whether the 
other allele is functioning. Non-producing clones may have a higher growth rate, 
as antibody production is a metabolic burden on producing cells. Frame and Hu 
(1990) showed that in a continuous culture over 2000 hours, the antibody titre 
fell by 50% and that this could be related to the increase in a non-producing 
population. They later showed (Frame and Hu, 1991) that five out of a panel 
of six non-producing clones had a higher maximum specific growth rate than the 
producing clone, along with a higher yield of cell mass on glucose and glutamine.
Periodic checks for non-producing clones along with proper cell banking ar­ 
rangements are required to avoid productivity loss. Sub-cloning of the cell line is 
an efficient method for removing non-producing clones and selecting clones that 
produce higher concentrations of antibody.
The factors affecting specific productivity have been discussed in the introduc­ 
tion (Section 1.2.2). Two of the factors that are affected by the mode in which a 
reactor is operated are cell cycle state and cell turnover rate.
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7.3.1 Cell Cycle
The positive association between percentage of cells in the Gl stage of the cell 
cycle and specific productivity suggests that devices that encourage slow growth 
should also encourage high specific productivity, as Hybridoma cells extend the Gl 
portion of their cell cycle as their growth rate declines (Park and Ryu, 1994). Cells 
in the dialysis reactor spend long periods of time with no net growth, therefore 
apparently no cell turnover. In fact cell turnover is occurring (see next section).
The flow cytometry results for TBC3 cell cycle are confusing because there 
appears to be an oscillation in the proportion of cells in the different stages of 
the cell cycle. This suggests that the cells are dividing in a synchronous manner. 
Other reports of this cell line have shown a more constant cell cycle pattern with 
time in continuous culture steady states (Al-Rubeai and Emery, 1993).
7.3.2 Cell turnover
Cell turnover has been discussed generally in the introduction (Section 1.2.2) 
and in relation to cell concentration (Section 5.2.2.1). Its importance in specific 
productivity lies in the fact that TBC3, along with other cell lines, stores IgG 
(Al Rubeai et a/., 1992). This antibody may be released upon cell disruption, 
adding to the measured pool of antibody and increasing the productivity. TBC3 
has been shown to store 15 xlO~9# IgG per cell (Al-Rubeai and Emery, 1990). 
Given a turnover rate of 0.15 d-1 (see Section 5.2.2.1) the antibody release rate 
is 0.1 xlO~9# cell^hour"1 . This is 2.3% of the overall antibody production rate. 
Cell lines vary in the quantity of IgG that they store and therefore of the effect 
of this parameter. For example with the cell line 1.13.17 no stored antibody was 
detected (Al Rubeai et al, 1992).
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Along with functional antibody there will be quantities of non- or partly- 
assembled chains as unglycosylated antibody present in the cell, which will also 
be released. Our ELISA is activity based and will pick up whole or part molecules. 
Section 7.2.1 showed that unassembled chains did not form a significant part of 
the final product.
Chapter 8
Other Cell Lines
8.1 Recombinant Interferon-7 production in Chi­ 
nese Hamster Ovary cells
We have seen with a hybridoma cell line that dialysis culture allows higher cell 
densities to be maintained in quasi-steady states and also the accumulation of 
antibody product. However cell lines are known to differ from each other in 
many ways (see Section 1.2.3) and information gained from one cell line does not 
necessarily apply to another. The very low steady state cell viabilities seen with 
TBC3 in dialysis culture have not been observed in other reports of dialysis culture 
(Butler, 1987; Kasehagen et a/., 1991). Low viabilities are suggestive of a relatively 
high cell death rate and thus a high rate of release of intracellular proteases (see 
section 7.2.1). We next examined a different cell line/product system to identify 
under dialysis culture conditions whether different dynamics of cell and product 
turnover would be exhibited.
Chinese Hamster Ovary (CHO) cell lines have been extensively used for recom-
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binant gene expression because of their genetic stability and high plating efficiency 
Many auxotrophic mutants are available allowing a choice of selection systems. 
CHO cells grow well in suspension or in monolayers.
Interferon-7 is a cell regulatory glycoprotein produced by T-lymphocytes and 
Natural Killer cells (another type of lymphocyte) in response to virus infection, 
endotoxin and a variety of mitogenic and antigenic stimuli (Dawson, 1991). It is a 
small protein consisting only of 176 amino acids. There are two glycosylation sites, 
both of which may or may not be filled. Interferon-7 ig one °f a grouP of proteins 
that induce a non-specific anti-viral state in neighbouring cells. Interferon-7 also 
powerfully inhibits cell growth of both normal and transformed cells. Possible 
clinical uses include antiviral treatment, particularly of AIDS, tumor therapy and 
as a replacement in the treatment of certain forms of autoimmune disease. In 
the human body it is present in tiny quantities, so the cost of purifying it from 
human tissue is prohibitive. Interferon purified from this source may also contain 
contaminating virus and other cytokines which can lead to side effects in vivo. 
The interferon-7 gene has however been cloned and been expressed in a number 
of different cell lines, including Escherichia coli and CHO cells (Hodgson, 1993). 
Currently 18 different companies are developing or have developed expression 
systems for Interferon-7 (Hodgson, 1993).
Figure 43 shows a dialysis culture of CHO cells. An inoculum of 0.4xl06 
cells ml" 1 in RPMI 1640 with 1 mg ml"1 of methotrexate which maintains a 
selection pressure for the plasmid containing the interferon gene, was placed in an 
LSL 2 litre reactor, setup for dialysis as in Figure 28. pH was controlled at 7.0 by 
automatic NaOH and HC1 addition, DOT was controlled at 20% by intermittently 
passing pure oxygen through 1 metre length of thin walled silicone tubing. Dialysis
CHAPTERS. OTHER CELL LINES 151
was begun immediately after inoculation, with a fresh feed flow rate of 0.5 Id" 1 , 
using RPMI 1640 with methotrexate.
The cell concentration increased for the first 284 hours. The increase was a 
linear function of time, suggesting therefore that cell growth was limited by the 
supply of some component of the medium, which was being incorporated into the 
biomass. TBC3 under similar conditions increased exponentially in concentration 
towards its steady state and therefore was limited by the maximum rate at which 
it could grow. The rate of growth was 0.3xl06 cells ml" 1 day"1 . Growth rate 
appears to be controlled by the fresh feed flow rate. Such growth would continue 
until the cells became limited by the demand for energy for maintenance, which 
is high in animal cells in comparison to bacteria (Miller et a/., 1989b).
The maximum cell density achieved was 4.2xl06 cells ml" 1 . Under similar 
conditions TBC3 would achieve 1.5xl06 cells ml" 1 . CHO has a much higher 
growth yield on the basal medium than TBC3, in terms of cell numbers, though 
of course not necessarily in terms of weight of biomass which is considered the more 
important indicator. Greater efficiency of use of medium means that very high cell 
concentrations could be achieved with this cell line. Using the same membrane 
area acting at its most efficient and a fresh feed flow rate of 1.0 1 d"1 , 7.5 x 106 cells 
ml" 1 (from equation 9) should be achievable Also medium optimisation should be 
possible to further increase the maximum cell density. From 284 hours to 380 
hours the cell concentration decreased in a linear manner, at a rate of 0.16xlO6 
cells ml" 1 day" 1 . Population viability decreased slowly over the course of the 
culture eventually reaching 75%. The dramatic decreases in viability observed 
with TBC3 as the culture reaches its steady state cell density did not occur. 
The Interferon-7 concentration was determined at three points in the culture.
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Figure 43: Growth and interferon-7 production of CHO under dialysis culture. 
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Table 17: Production of Interferon-7: a yields in dialysis and continuous culture.
Dialysis Continuous
Basal Medium Used (litres)
Serum Used (litres)
Duration (hours)
Maximum cell concentration (xlO6 cells ml" 1 )
Viability Index (xlO6 cells ml^hr"1 )
Interferon-7 concentration (xlO6 International Units ml" 1 )
Specific Production (xlO3 IU 106 cells ml" 1 )
Interferon-7/Basal medium (xlO6 IU I" 1 )
Interferon-7/Serum (xlO9 IU I" 1 )
Medium Cost (£/109IU)
9
0.05
381
4.2
1250
7
5600
0.78
140
£2.27
3.81
0.19
381
1.1
418
0.5
5000
0.5
10
£14.20
The final concentration achieved was 7xl06 International Units ml" 1 . This is 
consistant with a specific production rate of 5.6 x 103 IU 106cells ml"1 (Table 17). 
A continuous culture of the same cell line and medium, at a dilution rate of 0.01 
hr" 1 gave a steady state interferon-7 concentration of 5xl06 International Units 
ml" 1 giving a specific productivity of 4.5 x 103 IU 106 cells ml"1 . The specific 
productivity is roughly constant throughout the run. There is however a serious 
discrepancy between these results and those of Hayter et al (1992b, 1992a) for the 
same cell line. These specific productivities are a factor of 1,000 higher. Hayters 
group use a serum free medium formulation but this is unlikely to explain such a 
large difference. Alternatively, genetic variation may account for the differences. 
A more likely explanation of the difference is an error in the concentration of the 
standards used to calibrate the ELISA. Smiley et al. (1989) with another CHO 
cell line producing interferon record specific productivities of 7.5 x 103 IU 106cells 
ml" 1 .
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The yield of inteferon on basal medium is slightly increased over that observed 
in the continuous culture, this is probably a reflection of the higher specific pro­ 
ductivity. The use of a membrane to retain the high molecular weight fraction of 
the serum has once more led to a substantialy higher yield of Interferon on serum 
(14 fold). The difference in the yield on serum is the principal reason for the 
savings in medium cost (by a factor of 6). The Foetal Calf Serum is substantially 
more expensive than the New Born Calf Serum and thus the reduction in cost of 
medium is much more dramatic than that seen with TB/C3 (see table 16.
Figure 44 shows another dialysis cultivation of CHO cells, identical to the 
previous one except that flow rates of 0.1 Id" 1 and O^Sld" 1 were used. Steady 
state was quickly achieved of 0.75xl06 cells ml" 1 at 0.1 Id" 1 . The dilution rate 
was then changed to 0.25 Id" 1 and a steady state cell density of 2.0xl06 cells ml" 1 
and a viability of 83% was achieved. The steady state cell densities of Figures 43 
and 44 when plotted against fresh feed flow rate fall on a straight line with an 
intercept at zero.
Flow cytometry was used to determine cell size and the percentage of cells 
in each stage of the cell cycle. Forward scatter measurements showed that the 
cells were bigger at the start of the quasi-steady state but subsequently decreased 
showing that the cells were not truely at a physiological steady state (Figure 45 and 
Figure 47). The cells were stained with Propidium Iodide which intercalates with 
double stranded nucleic acids. The DNA content of each cell can thus be measured 
and the proportion of cells in each stage of the cell cycle estimated (Figure 46). 
An initial periodicity of the percentage of cells in.each cell cycle stage settled down 
later during the steady state (Figure 47). Because of the periodicity in the early 
readings no inference about differences between exponential and stationary phase
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Figure 44: Growth and interferon-7 production of CHO under dialysis culture at 
low perfusion rates. Cell concentration (O)>% viability (D)
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cells could be drawn which might relate cell cycle state to specific productivity.
Referring to Figure 33 cell viability is a balance between cell growth, cell death 
and dead cell disintegration. To measure the cell growth rate we compared the 
rate of incorporation of tritiated thymidine into DNA from cells from a batch 
culture growing at fj,max and that of the dialysis culture. The average counts per 
minute (cpm) of triplicate samples of CHO cells was 2921, the cell count was 
1.7xl06 cells ml" 1 . 24 hours later the cell count was 3.7xl06 cells ml" 1 , which 
gives a growth rate of 0.0377 hours" 1 . The average cpm of the cell count was 645, 
or 22% of the cell count for the batch culture. This gives a cell growth rate of 
0.008 hours" 1 . From equation 22 therefore k* = 0.008 and kr = 0.034 hours" 1 . 
Hayter et al. (1992b) operating a continuous culture at a dilution rate of 0.01 
observed a steady state cell viability of 80%. The similar viability suggests that 
the mechanisms of cell death and dead cell disintegration were similar in this 
system.
Specific productivity has been shown to be a linear function of growth rate for 
CHO by a number of workers (Hayter et al., 1992b; Leelavatcharamas et a/., 1994). 
Leelavatcharamas et al. (1994) in this laboratory also found a direct relationship 
between the proportion of the cells in the S phase of the cell cycle and growth 
rate. In Table 18 specific productivity, DNA synthesis rate and flow cytometry 
data are presented. Growth rate during apparent steady states is approximately 
0.008 hr"1 . Specific productivity was measured at 5.60 and estimated at 5.00 . 
The specific productivity of a chemostat at a dilution rate of 0.01 was 5.6 x 103 
IU 106cells ml" 1 . In a continuous culture at 100% viability specific growth rate is 
equal to the dilution rate. Below 100% cell viability the growth rate is increased
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Figure 45: Forward scatter measurements of the CHO cells in Figure 44
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Table 18: Comparison of predicted levels of % S phase cells, growth rate and 
specific productivity from their measured values.
Specific Productivity
DNA Synthesis
%S Phase
S Phase Cells 
%
32
30
35-25 
30
Growth rate 
hr- 1
0.009
0.008
0.012-0.002 
0.08
Specific Productivity 
xlO3 IU 106 cells ml" 1
5.6
5.0
0.6-6.5 
5.0
from the dilution rate by the death rate in the culture (Kwong et a/., 1989).
Li = D + Lid (23)
where the death rate Ltd is the dilution rate multiplied by the proportion of viable 
cells.
^ = D (2) (24)
\XV J
The cell viability of the continuous culture is 93% and therefore LI = 0.0108. 
The specific productivities of the dialysis and continuous systems relate to similar 
growth rates (0.008 vs. 0.01).
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8.2 Insect Cell Growth under Dialysis Culture
The Baculoviradae are a large group of viral pathogens of arthropods, which 
mainly infect only a single or a few related species (Vlak, 1992). They are large 
double stranded circular DNA viruses that produce large proteinaceous capsules 
called polyhedra. The polyhedra principally consist of two proteins: the poly- 
hedrin protein and plO whose role is not understood. They are produced to very 
high concentrations in the host cell. Together these two proteins can constitute up 
to 50% of the total cellular protein, and in vitro both these proteins are dispens­ 
able. Promoters of both genes have been used in the construction of expression 
vectors. The most common combination has been the use of Autographa califonica 
nuclear polyhedrosis virus (AcNPV) with cell lines from Spodoptera frugiperda e.g. 
SF9. Insect cells grow well in static or suspension culture and perform many of the 
necessary post-translational modifications of mammalian cells. This system has 
therefore become popular for the production of quantities of protein for research 
use, because production of the recombinant vector is simple and yields of correctly 
folded and modified protein are high. However, it does not correctly glycosylate 
all proteins, there is a high degree of N-terminal degradation of secreted protein, 
also some proteins are not secreted efficiently (Grabenhorst et a/., 1992) and this 
system is therefore not suitable in all cases.
The initial step in the infection process is the uptake of the viral particle via 
receptor-mediated endocytosis. The nucleocapsid then enters the nucleus and is 
uncoated, host macromolecular synthesis is shut down and the cytoskeleton re­ 
arranged. Transcription of the "very late" genes including plO and polyhedrin, 
begins at around 18 hours post infection. Production continues for 3-5 days after 
this as the cells are killed.
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Many authors have found that maximum production of recombinant protein 
occurs if the cells are infected whilst in exponential phase (Summers and Smith, 
1987). However recently several groups have found that by replacing the medium 
with fresh, immediately prior to infection maximum specific productivities can 
be obtained throughout the batch growth cycle, at least until cell viabilities fall 
(Radford et al, 1992; Reuveny et a/., 1993; Wang et al, 1993). Therefore it is 
possible to wait until the maximum cell density occurs before infecting the cells.
Medium exchange in the work referred to above was achieved by centrifuging 
the cells out of the medium. It would be much more practical on a larger scale to 
exchange medium by filtration or dialysis. Indeed there are reports of the use of 
spin-filter devices (Weiss et a/., 1992) and filtration devices (Caegn and Bernard, 
1992; Guillaumme et a/., 1992; Jager et a/., 1992; Kloppinger et a/., 1990) in 
growth and infection, but not infection alone. Dialysis culture is another possible 
method of performing this medium change operation. Its advantage over filtration 
methods is that there is no necessity to add serum to the perfusing medium and 
that product is accumulated to high concentrations
Figure 48 shows the growth of SF9 cells in TC100 medium plus 5% foetal calf 
serum, in an LSL bioreactor fitted with a perfusion device (as in Figure 35). DOT 
was controlled via headspace gassing with pure oxygen, pH was not controlled, 
but only varied by +/- 0.2 unit. One metre of dialysis tubing was used. The 
dialysate medium, basal TC100, was fed at 0.5 Id" 1 .
Dialysis was begun at 63 hours, at which point cell growth was already slowing 
down and the cell concentration then only increased to 1.3xl06 cells ml" 1 . This 
is less than half of what has been achieved in batch culture in this lab with the 
same cells and medium (Hild et al, 1992). Addition of 5% FCS to the feed did
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Figure 48: Growth of an SF9 culture in a dialysis reactor. Cell concentration (O)» 
% viability (D).
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not enhance the cell density. Viability decreased over the entire course of the 
experiment. Despite the lack of growth glucose use by the cells increased during 
dialysis, the concentration reaching zero as the cell numbers started to decline. 
No contamination could be detected.
To try and assess whether the low cell density achieved was due to the physi­ 
cal conditions in the fermenter, or to the removal of some essential low molecular 
weight substance present in the serum a 30 ml sample was removed from the fer­ 
menter at 161 hours, IxlO6 cells ml"1 , 65% viable. This sample was split into 
7.5ml aliquots and various supplements were added, following which they were 
incubated in T-flasks at 28°C for 52 hours. The supplements were 5% FCS, 5% 
NBS, 1% lipid mixture (Gibco) 5% of 5% meat peptone in PBS and a control 
with no supplementation. No cell growth was observed in any of the flasks. Ta­ 
ble 19, shows however that cells in the FCS flask maintained their concentration 
for longer than the others, lipids and NBS were equally ineffective and peptone 
had a negative effect, i.e. death was accelerated.
Significantly higher cell concentrations can be achieved in batch cultures by 
the use of optimised media (Weiss et a/., 1992). This suggests that the TC100 
basal medium used is far from being optimal for cell growth. A more complete 
medium may allow cell growth under dialysis conditions. The additions made to 
samples from dialysis culture may have been ineffective because of a physiological 
change in the cell caused by earlier stresses.
Figure 49 shows the post inoculation behaviour of cells infected with a recom- 
binant AcNPV for Escherichia coli /?-galactosidase. SF9 was grown in four stirred 
Duran bottles at 500 ml volume until the maximum cell density was reached at 
0.9xl06 cells ml" 1 . The contents of the bottles were mixed and divided between
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Table 19: Growth of SF9 cells in batch, taken from a dialysis culture in stationary 
phase, with various supplements
Supplement Cell Cone. xlO6 cells ml" 1 Viability
Control
FCS
NBS
Lipids 
Peptone
0.63
0.93
0.75
0.75 
0.53
0.56
0.62
0.62
0.62 
0.51
two 1 litre reactors, operated as described in the previous experiment. The re­ 
actors were identical except that one was set up for dialysis. The fresh feed flow 
rate was 0.5 1 d" 1 of TC100.
Cell concentration and viability declined at the same rate in both reactors. 
Cell concentration started to fall 30 hours post infection, reaching 0.2xl06 cells 
ml" 1 at 120 hours. Viability declined linearly with time, from 95%, reaching 20% 
by 120 hours, /?-galactosidase production started at 20 hours post infection in 
the dialysed reactor and 40 hour in the batch reactor. By 120 hours there was 
52 xlO6 units ml"1 in the non-dialysed culture and 50 xlO6 units ml" 1 in the 
dialysed culture, an increase of 1.7x.
Medium change, via dialysis seems responsible for a significant change in the 
yield of protein, from 58 units cell" 1 to 100 units cell"1 (Table 20). That this 
should occur is surprising since the cells would not grow under the same conditions. 
However the change in cell physiology upon infection and therefore probably the 
cells nutritional requirements is profound.
On a per litre of basal medium basis however, dialysis is half as efficient as 
batch, leaving an overall cost of medium per unit slightly higher under dialysis. 
Insect cell culture basal media are more expensive than mammalian cell culture
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Figure 49: Comparison of the the behaviour of a SF9 culture infected with Ac- 
NPCV recombinant for /?-galactosidase. The culture was split in two parts and 
put in two identical bioreactors, one of which was operated in batch mode (o), 
the other in dialysis mode (y). Time is post infection.
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Table 20: Comparison of the productivities of batch and dialysis culture of SF9 
for the production of /3-galactosidase
Dialysis Batch
Basal Medium (1) 
Serum (1) 
Duration (hrs)
Initial cell concentration (xlO6 cells ml" 1 ) 
/3-galactosidase concentration xlO6 IU I" 1 
/3-galactosidase/cell (IU cell"1 ) 
/9-galactosidase/serum (xlO9 IU I" 1 ) 
/?-galactosidase/basal medium (xlO6 IU I" 1 ) 
£/109 IU ml" 1
3.5
0.05
120
0.9
0.90
100
18
260
0.20
1
0.05
120
0.9
0.52
58
10
520
0.18
basal medium because of the large amounts of amino acids they contain. Reduc­ 
tions in the amount of medium used may be possible without compromising the 
yield of recombinant protein. This is because the rate of medium feeding was not 
optimised. There is an increase in metabolic activity immediately subsequent to 
infection which lasts for about a day (Kioukia et a/., 1994). After this time the 
rates of nutrient utilisation decrease and cells start to die. Perfusion should be 
concentrated in this time period and afterwards decreased. One possible method 
of deciding the perfusion rate is by controlling the glucose concentration.
Chapter 9
Conclusions
1. Hybridoma cells grew in dialysis culture.
la. A steady state viable cell concentration of 4x 106 cells ml" 1 was achieved, 
five times that seen in batch culture.
Ib. Steady state viability was 30-50%.
le. During the steady states TBC3 was dividing at l^xlO"3!^"1 . The 
steady state viability was therefore the result of a dynamic equilibrium 
between the rates of cell division, death and disintegration.
Id. No serum was added to the perfusing medium, and apart from that 
initially batched, no further serum addition to the reaction volume was 
required.
le. The system produced considerable savings in medium cost because of 
savings in serum use.
If. Some evidence exists for proteolytic degradation of the monoclonal an­ 
tibody product.
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2. The value of these steady states can be simply predicted.
2a. Under the conditions pertaining in the experiments cell density was 
limited by transport of metabolites across the membrane and depended 
on the cell type and medium used.
2b. A model was constructed and verified for a range of perfusion rates and 
membrane areas.
2c. Cell density was related to fresh feed flow rate following a saturation 
kinetic argument.
2d. The model did not predict performance when the medium concentration 
or the cell physiology changed.
3. CHO-320 cells also grew in dialysis culture.
3a. A viable cell density of 4xl06 cells ml" 1 at 0.5 Id" 1 perfusion rate were 
achieved.
3b. Steady state viabilities were 70-80%
3c. CHO-320 cells grew in linear fashion during their approach to the steady 
state. This suggests that this growth was limited by the supply of some 
component of the biomass which was being supplied in a linear manner.
3d. Interferon-7 was expressed and accumulated to high concentration (7 x 
107 IU ml" 1 ).
4. Expressed protein product yield was strongly influenced by dialysis when 
using recombinant virus infection of the insect cell line SF9.
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4a. Exchange of nutrients via dialysis permitted recombinant virus infected 
SF9 cells to produce twice as much /3-galactosidase.
4b. SF9 did not grow in dialysis culture with basal medium alone, nor could 
growth be restarted by adding serum to the perfusing medium or by 
removing samples and growing them in batch culture.
Chapter 10
Recommendations for Future 
Work
10.1 Reactor Design
Cell concentrations within the current design are limited by transfer through the 
membrane. Since the majority of the hindrance to transport is in the Nernst films 
on either side of the membrane, methods of increasing the Reynolds Numbers 
should be investigated.
On the outer (reactor) side of the membrane efficient impeller design and 
operation strategies should allow the Reynolds Number to be maximised whilst 
minimising cell damage.
On the inner side of the membrane the Reynolds numbers are extremely low. 
Strategies immediately presented include decreasing the tube diameter and in­ 
creasing the liquid flow rate. Both these solutions would result in increased pres­ 
sure drop across the membrane, leading to liquid transfer into the reactor. This
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transfer could be allowed for in reactor operation.
Methods of increasing flow rate whilst decreasing the pressure drop across the 
membrane should be explored. These might include; minimising the lengths of 
each piece of tube, arranging the tubing so it is straight not coiled; balancing the 
pressures on either entry or exit to the tubing, placing devices in the tubing to en­ 
courage turbulance; introducing the perfusate to the membrane with a rotational 
motion.
Scale up of reactor volume is also mainly a problem of arranging increasing 
lengths of tubing in the reactor. If the diameter of the tubing and the volume it 
takes up in the reactor is kept constant then the length increases in proportion 
to the volume. Methods of arranging and supporting this length of tubing will 
become increasingly mechanically critical.
The dialysis membrane could also be used for bubble-free oxygen transfer into 
the culture. A one litre reactor with a cell density of 2x 106 cells ml" 1 would have 
an oxygen demand of 0.05-1.0 mM 62 hr" 1 . Under present conditions using oxygen 
saturated medium (ImM I" 1 ) 0.6 mM 02 hr" 1 passes the membrane. Assuming 
a membrane transfer coefficient for oxygen of 0.16 (similar to that of NH4 ) and 
the standard configuration then the oxygen transfer rate will be 0.06 mM hr" 1 . 
The transfer rates of oxygen should be experimentally determined. Given the 
possibilities for increases in membrane area, and increasing membrane transfer 
coefficients this value could be substantially increased.
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Appendix A
Appendices
A.I Data
A.1.1 Batch Experiments
Batch growth of TBC3, pH 7.0 DOT=50%, agitation speed=100 rpm, medium: 
RPMl 1640, 5% NBS. 10%volume inoculum. Figures 9 and Figure 10
Time 
hrs
0
16.5
24
46
48
63
88
Cell 
xlO5 cells ml- 1
6.2
13
13.8
20.3
20.6
18.3
12
Viability 
%
98
98
98
98
96
82
45
Glucose 
mMol I' 1
8.9
4.3
3.8
4.1
4.5
2.1
1.3
Batch growth of PQXl, pH 7.0 DOT=50%, agitation speed=100 rpm, medium: 
RPMl 1640, 5% NBS , 10%volume inoculum. Figure 11.
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Time 
hrs
0
11
24
35
44
58
70
82
96
Cells 
xlO5 cells ml' 1
1.1
1.5
1.7
3.3
4.5
7.1
4.1
3
2.2
Glucose 
mMol I- 1
2
1.7
1.4
1.3
0.9
0.64
0.55
0.42
0.3
Antibody 
Mg ml" 1
2
4
5
9
15
20
26.5
33
35
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A. 1.2 Biopro Experiments
Effect of Biopro Concentration on the batch growth of TBC3. 50 ml volume in 
150ml stirred bottles. 10% volume inoculum. Medium= RPMl 1640 and 5% 
NBS.
Time 
hr
0
24
48
64
74
88
115
Biopro Concentration %w/v 
0 0.1 0.25 0.50 0.75 1.00
1.0 1.0
2.0 2.1
2.9 2.7
4.0 4.2
6.9 7.0
4.1 4.0
1.2 1.1
1.0 1.0
1.8 1.6
2.4 2.4
3.5 4.0
7.5 7.0
5.8 6.3
4.8 3.9
1.0 1.0
2.2 2.4
4.5 4.4
4.6 4.6
8.5 8.5
5.3 5.2
3.1 2.8
1.0 1.0
2.4 2.4
6.0 5.5
6.5 63
7.8 8.1
5.6 6.1
3.6 3.6
1.0 1.0
2.4 2.2
5.4 5.5
5.0 5.0
7.5 7.5
5.7 5.7
4.2 4.8
1.0 1.0
2.6 2.3
6.5 6.4
4.7 4.2
4.2 4.2
5.3 5.6
2.2 2.2
Comparison of Biopro with FCS and Peptone, in the batch growth of TBC3. 50 
ml volume in 150ml stirred bottles. 10% volume inoculum. Medium= RPMl 1640 
and 5% NBS.
Time 
hr
1
24
31
44
55
68
75
95
NBS NBS NBS FCS FCS. 
Bp Pep Bp
1 1
2.5 2.7
4.7 4.7
4.2 4.6
9.6 9.8
5.0 5.8
2.8 2.5
0.25 0.4
1 1
2.5 2.9
4.9 5.1
10.2 9.9
10.1 10.4
8.1 8.5
4.3 4.6
1.25 1.0
1 1
3.0 2.8
7.0 6.9
12.0 11.8
9.0 8.5
4.3 4.0
1.6 1.5
0.15 0.1
1 1
2.8 3.1
6.9 7.2
12.2 12.8
12.0 10.4
10.0 9.0
4.2 3.6
0.5 0.3
1 1
3.0 3.3
.7.0 6.6
12.8 11.5
12.1 12.0
11.0 10.4
4.0 3.5
1.2 1.3
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A. 1.3 Addon Lnrtnto ;vn<] Ammonia Batch. Cultures
Hatch culture^ o| i B/C3. Ammonium clvionde was added then pll was adjusted 
]>;u-k to 7.0 In-fore i!ir mod : ''ell and 
resnsoended in the medium, C . . ,
Time
0
' !
Is
8f>
ilO ,
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0.
0.
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A. 1.4 Small Scale Dialysis Experiments
Dialysis culture of TBC3, in bottle device, media= RPMl 1640, serum=5% NBS. 
Perfusate= RPMl 1640 only. Figure 13.
Time Cell Glucose Ammonia 
hr xlO5 cells ml-1 mMol I'1 mMol I"1
0
23
49
64
96
120
140
150
170
1.7
4.5
13
15
23
15.9
16
18
14.3
11.1
8.3
7.2
7.7
3.8
5
5
3.3
4.4
2
1.5
1.3
1.4
0.7
0.9
0.9
0.6
0.8
Dialysis culture of PQXl, in bottle device, media= RPMl 1640, serum=5% NBS. 
Perfusate RPMl 1640 only. Figure 14
Time 
hrs
0
11.5
23
32
48
62
82
94
Cell 
XlO5 cells ml- 1
2.66
3.7
6
9.7
13
17
23
24
Viability 
%
97
98
99
99
97
96
95
94
Glucose 
mMol I' 1
11.1
8.3
7.2
7.8
3.9
5.0
5.0
4.5
Ab 
fig ml"1
1
2
10
17
32
54
62
87
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A, 1.5 Large Scale Dialysis Experiments
Effect of Membrane Area on steady state cell concentrations. All at 0.5 v/v/d per- 
fusion rate. DOT=50%, pH=7.0, agitation rate=100 rpm. Medium= RPMI 1640 
and 5%NBS. Perfusate= RPMI 1640 plud an additional 5.5 mMol l^Glucose; 
and 0.25 % w/v Peptone, 0.05% Pluronic F68. Figure 19.
Time 
hrs
0
24
48
72
96
120
144
168
192
210
240
252
Cell Concentration 
Length of Membrane 
0.25 0.5 0.75 1
5.3
11.5
10
8.5
8.3
8.2
8.4
8.3
4.4
10
13.2
12
11.8
12.2
12.2
12
12
12
5.1
9.1
12.5
15.1
18.8
16
15
14.6
15.3
15
15
15.3
3.1
12
18
20
21
20
19
19
20
20
19.5
3H Incorporation 
0.5 Control 
cpm cpm
760
770
657
704
607
553
691
547
700
814
112
75
111
90
76
86
64
107
84
74
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Dialysis culture of TBC3. pH 7.0, DOT 50%, agitation rate= 100 rpm. Medium= 
RPMI 1640 with 5% NBS. Perfusate: RPMI 1640 with an additional 5.5 mmol/1 glucose, 
0.25 % peptone, 0.05% Pluronic F68. Reac= reactor, Perf= Perfusate Figure 21.
time 
hr
0
22
31
48
56
71
79
95
104
119
140
166
192
216
238
262
272
286
297
312
320
335
345
359
371
PR
1/d x
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
1
1
1
1
1
1.5
1.5
1.5
1.5
2
2
2
2
2.5
2.5
2.5
2.5
Cell Ab 
105 cells ml- 1 ^g ml" 1
3.
9.
17
21
19
20
19
19
28
26
28
27
28
32
36
35
32
40
40
37
37
42
41
40
41
8
7
.6
.0
.8
.1
.1
.4
.1
.0
.3
.6
.7
.5
.8
.2
.4
.6
.0
.4
.0
.6
.8
.9
.8
28.3
50.8
60.5
108
130
130
160
200
205
250
300
370
490
500
586
760
770
840
870
1020
12 1
1100
1060
1170
1220
Concentration 
Reac Perf 
Glucose
14
12
8.
6.
7.
7.
7.
7.
7.
7.
7.
7.
8.
8.
7.
7.
7.
8.
8.
8.
7.
7.
7.
7.
8.
.4
.7
8
3
3
5
0
2
1
6
8
1
0
2
8
8
7
5
1
1
5
9
5
2
4
16.5
13.5
10.4
9.5
10.1
9.4
9.3
10.0
11.6
11.3
11.6
12.6
11.7
12.6
13.3
12.8
12.7
12.5
13.1
13.0
12.8
13.0
13.1
14.2
13.1
Reac Perf 
Lactate 
mmol/1
0.3
0.8
1.2
1.6
1.5
1.6
1.5
1.5
1.3
1.3
1.2
1.2
1.2
1.1
1.1
1.1
1.1
1.1
1.0
1.1
1.1
0.9
1.0
1.1
1.0
0.2
0.7
1.1
1.3
1.3
1.3
1.3
1.3
0.9
1.0
1.0
1.0
0.9
0.8
0.7
0.7
0.8
0.7
0.7
0.7
0.7
0.6
0.5
0.6
0.6
Reac Perf 
Ammonia
2.1
4.9
8.0
10.2
9.8
8.1
8.3
9.5
7.6
8.3
7.8
9.0
8.0
7.7
7.2
8.3
7.0
7.1
8.1
7.3
7.6
7.5
7.1
7.2
7.1
1.4
3.4
5.7
8.0
6.9
7.2
7.3
7.2
5.3
4.7
4.6
5.1
5.1
4.0
4.0
4.5
4.0
3.4
3.5
3.4
3.6
3.3
3.0
3.1
3.4
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Dialysis culture of TBC3 at half normal membrane area, effect of perfusion 
rate. Figure25
Time Cell No. Viability Perfusion Rate
0
24
48
72
96
122
145
169
192
216
240
264
288
312
336
360
384
408
432
456
480
504
528
4.6
9.0
20.1
16.3
11.8
10.6
10.3
10.1
10.0
10.3
17.3
20.0
21.0
22.8
21.3
22.5
23.0
23.2
23.0
24.0
33.0
38.0
37.0
95
97
98
72
51
46
42
39
33
35
48
31
32
28
32
34
31
27
26
28
30
35
40
0.5
1.0
1.5
2.0
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Dialysis culture of TBC3. pH 7.0, DOT 50%, agitation rate= 100 rpm. 
Medium= RPMI 1640 with 5% NBS. Perfusate= RPMI 1640 plus 0.25 % peptone, 
0.05% Pluronic F68. Figure 35.
TIME Cell Viab PR PV SERUM Protein Antibody 
HRS xlO5 cells ml- 1 % V/V/D L ml mg/ml pg ml"1
0
24
50
70
118
144
170
194
260
284
308
332
357
383
405
429
453
478
4
8
14
15
15
15
14
15
17
17
20
27
18
25
20
33
20
15
95 0.5 0.5 1.35 15
95 32
80 64
50 1 102
30 143
162
1 1.2 232
454
25
881
3
25 1005
1152
25 1138
5 1239
1477
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Metabolite concentration for the previous table. Figure 36
FER PER FER PER FER PER
Glucose Lactate Ammonia
mMoll- 1 mMoll- 1 mMol I"1 mMol l~l mMol I'1 mMol T1
4.01
3.80
3.44
3.13
2.40
1.67
2.87
3.23
3.33
2.97
0.00
0.89
0.00
0.00
0.00
0.00
0.00
1.67
4.38
6.20
3.28
4.95
6.20
7.14
8.13
5.21
6.25
4.17
4.64
5.37
0.00
8.711
6.41
6.90
8.09
9.27
9.72
10.68
7.22
5.72
6.51
8.23
10.40
11.20
12.27
10.79
5.24
7.11
7.77
9.53
7.48
5.78
5.15
6.64
7.50
6.93
7.74
8.03
0.4942
0.56
0.71
1.20
0.56
0.85
0.73
0.81
0.87
0.81
0.76
0.66
0.79
0.89
0.97
0.91
0.67
0.62
0.73
0.64
0.59
0.64
0.65
0.64
0.64
0.69
0.78
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Dialysis culture of TBC3. pH 7.0, DOT 50%, agitation rate= 100 rpm. 
Medium= RPMI 1640 with 5% NBS. Perfusate= RPMI 1640 with an additional 
5.5 mmol/1 glucose, 0.25 % peptone, 0.05% Pluronic F68. Figure 29.
Time Cell Concentration Viability Antibody Concentration 
hrs xlO5 cells ml" 1 % fig ml'1
0
24
47
72
96
122
148
168
191
220
262
270
271
284
311
334
357
410
435
7.3
12
20
23
19.5
15.5
14.9
14.6
14.7
15.3
15.7
15.6
8.7
11.3
20
19.7
18.5
15
14.8
97
98
92
89
70
43
41
44
38
39
43
40
38
38
42
45
33
36
35
24
67
130
221
308
385
452
502
560
634
744
766
330
362
434
511
586
737
800
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Dialysis culture of TBC3. pH 7.0, DOT 50%, agitation rate= 100 rpm. 
Medium= RPMI 1640 with 5% NBS. Perfusate= RPMI 1640 with an additional 
5.5 mmol/1 glucose, 0.25 % peptone, 0.05% Pluronic F68. Figure 37.
Time 
hrs
0
20
44
68
104
118
142
168
194
209
233
317
340
360
378
400
424
450
Cell 
xlO5 cells ml'1
3
7.5
12.5
27
35
29
30
31
32
34
30
27
29
32
37
33
40
40
Glucose 
mMol I'1
5.8
6.1
3.2
3.2
5.0
5.0
5.0
4.9
4.0
4.4
4.2
4.1
6.0
6.2
6.3
9.1
9.2
10.2
PR
1/d
0.5
0.5
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
2.0
2.0
2.0
Serum Addition
start
stop
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Batch Growth of TBC3 in 50ml stirred bottles, with dialysed and whole serum. 
Medium= RPMI 1640, 0.25% peptone, 0.05%pluronic F68, 5% NBS.
time 
hr
0
21
31
45
56
70
80
91
Dialysed Nondialysed 
xlO5 cells ml'1 xlO5 cells ml-1
1.0 1.0
1.5 1.8
2.4 2.6
5.2 5.2
5.4 5.6
6.4 7.1
5.1 5.6
4.0 3.1.
1.0 1.0
1.9 1.9
2.5 2.5
4.7 4.4
5.5 5.5
8.6 8.8
8.6 8.6
5.4 5.3
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Dialysis culture of TBC3. pH 7.0, DOT 50%, agitation rate= 100 rpm. 
Medium: RPMI 1640 with 5% NBS. Perfusate: RPMI 1640 plus 0.25 % pep­ 
tone, 0.05% Pluronic F68. Figure 38.
time 
hrs
0
22
31
48
56
71
79
95
104
119
166
192
216
238
262
272
286
297
312
320
Cell 
xlO5 cells ml-1
4
13
17.3
20.6
18.6
19.8
20
20
23.3
27.4
27
27
28
28
32
32
27
30
29
33.3
glucose 
mMol I-1
4.3
2.3
2.9
2.9
1.8
2.3
2.6
2.3
1.7
1.8
1.0
0.0
0.0
1.0
1.6
2.3
2.8
2.9
2.9
antibody 
//g ml'1
25
52
87
64
62
134
151
182
313
562
557
410
557
560
589
337
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A standard dialysis culture of TB/C3 perfusion rate of O.Sld" 1 41
Time CN Viability % Median Forward Scatter 
hrs xlO6 cells ml"1 % arbitrary
0
24
68
76
93
100
116
124
163
180
0.3
0.57
0.92
1.24
1.96
2.09
2.06
2.09
2.03
2.1
99
93
93
78
77
75
72
72
54
51
435
414
352
452
507
523
523
512
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A.1.6 Other Cell Lines
210
CHO grown in Dialysis culture. pH=7.0, DOT=30rate=100 rpm. Medium=RPMI1640 
with 5% FCS, Perfusate=RPMI1640. Batch data provided by Mr Leelavatchara- 
mas for the same reactor and medium. Figure=43
Time 
hr
0
26
47
71
93
122
143
167
194
215
241
268
284
308
333
356
381
CN 
xlO5 cells ml' 1
0.6
1
1.08
1.67
1.99
2.53
3
3.1
3.39
3.6
3.91
4.07
4.2
4
3.9
3.7
3.54
Dialysis 
Viability Interferon-7 
% xlOMUml-1
98
98
98
99
97
97
95 1.3
94
94
95
94
87
88
87 4.19
87
86
78 7
Batch
CN 
xlO5 cells ml- 1
0
26
50
75
96.5
118.5
143.5
169
188
210
VI
%
1
0.21
0.439
0.78
1.3
1.43
1.34
1.23
1.07
6
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Dialysis culture of CHO under Figure 44
Time 
(hrs)
0
20
26
44
52
68
92
108
116
133
141
157
169
178
181
191
210
222
234
243
Cell No 
xlO6 cells ml'1
0.31
0.5
0.7
0.82
0.74
0.75
0.75
0.78
0.77
0.74
0.875
1.05
1.1
1.1
1.39
1.73
2
2
2
1.98
Viability Gl 
% %
97
94
96
94
90
84
81
81
77
72
79
81
84
89
80
85
82
83
85
87
71.5
42.5
69.4
61.6
41.3
53.1
57.8
58.7
60.8
60.3
G2
%
0
17.5
9.7
9.5
24.9
15.4
12
11
14.9
16.5
S 
%
28.5
38
20.9
28.8
33.6
31.5
30.1
21.8
24.3
23.2
Forward Scatter 
Arbitrary units
425.19
503.74
479.83
467.99
475.39
447.55
435.18
378.56
428.66
457.83
425.73
218.2
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Insect Cell Line SF9 in dialysis culture. pH=5.0 DOT=30%, agitation rate=100rpm. 
Medium=TC100 with 5% FCS, Perfusate= TCIOO. LSL reactor configuration. 
Figure 48
Time
0
17
39
61
88
112
135
161
185
208
232
264
286
302
CN
0.2
0.4
0.67
1.18
1.3
1.37
1.33
0.98
0.949
1.1
1.02
0.9
0.73
0.77
% Viability Dialysis Conditions
96
98
92
93
88
82
84
63
76
75
60
69
59
55
Batch
Dialysis TCIOO
Dialysis TCIOO +5% FCS + 5% NBS
Insect cell:SF9. Comparison between dialysis and convential batch (no) feeding 
regimes post infection. Identical LSL reactors. pH=5.0, DOT=30%, Medium=TC100 
with 5% FCS, Perfusate=TC100. Figure 49
Time 
hr
0
6
11
25
35
47
55
71
95
120
Batch 
Cell 
xlO6 cells ml-1
0.88
0.82
0.85
0.93
0.72
0.55
0.58
0.51
0.38
0.11
Dialysis 
Viab B-gal 
% xlO6 cells ml"1
94
91
92
84
72
52
53
49
47
20
Cell Viab B-gal 
%
0.88 93
0.86 93
0.86 93
0.9 87
0.92 82
0.65 62
0.67 63
0.44 56
0.25 36
0.15 25
